Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Mar. 31, 2021 | May 14, 2021 | |
Cover [Abstract] | ||
Entity Registrant Name | SHINECO, INC. | |
Entity Central Index Key | 0001300734 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2021 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --06-30 | |
Entity Reporting Status Current | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business Flag | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 4,009,288 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2021 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 | |
CURRENT ASSETS: | |||
Cash | $ 25,848,597 | $ 32,371,372 | |
Accounts receivable, net | 5,087,539 | 11,008,485 | |
Due from related parties | 130,407 | 120,939 | |
Inventories, net | 2,363,050 | 1,799,876 | |
Advances to suppliers, net | 16,743,140 | 13,313,946 | |
Other current assets | 5,847,512 | 905,380 | |
TOTAL CURRENT ASSETS | 56,020,245 | 59,519,998 | |
Property and equipment, net | 6,058,925 | 9,489,484 | |
Land use right, net of accumulated amortization | 1,263,683 | 1,195,943 | |
Investments | 4,515,124 | ||
Distribution rights | 1,125,603 | 1,043,887 | |
Long-term deposit and other noncurrent assets | 100,343 | 96,280 | |
Right of use assets | 3,022,178 | 3,227,895 | |
TOTAL ASSETS | 67,590,977 | 79,088,611 | |
CURRENT LIABILITIES: | |||
Short-term loans | 1,830,249 | 2,333,894 | |
Accounts payable | 278,633 | 148,209 | |
Advances from customers | 6,820 | 6,324 | |
Due to related parties | 1,131,376 | 1,355,919 | |
Other payables and accrued expenses | 7,776,146 | 4,018,684 | |
Operating lease liabilities - current | 97,560 | 97,633 | |
Taxes payable | 3,329,182 | 3,386,662 | |
TOTAL CURRENT LIABILITIES | 14,449,966 | 11,347,325 | |
Income tax payable - noncurrent portion | 566,022 | 566,022 | |
Operating lease liabilities - non-current | 449,162 | 401,891 | |
Deferred tax liability | 281,401 | 260,972 | |
TOTAL LIABILITIES | 15,746,551 | 12,576,210 | |
Commitments and contingencies | |||
EQUITY: | |||
Common stock; par value $0.001, 100,000,000 shares authorized; 4,009,288 and 3,039,943 shares issued and outstanding at March 31, 2021 and June 30, 2020* | [1] | 4,009 | 3,040 |
Additional paid-in capital | 30,037,504 | 27,302,051 | |
Statutory reserve | 4,198,107 | 4,198,107 | |
Retained earnings | 18,522,830 | 40,106,518 | |
Accumulated other comprehensive loss | (1,451,386) | (6,283,835) | |
Total Stockholders' equity of Shineco, Inc. | 51,311,064 | 65,325,881 | |
Non-controlling interest | 533,362 | 1,186,520 | |
TOTAL EQUITY | 51,844,426 | 66,512,401 | |
TOTAL LIABILITIES AND EQUITY | $ 67,590,977 | $ 79,088,611 | |
[1] | Retrospectively restated for effect of stock split on August 14, 2020. |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2021 | Jun. 30, 2020 |
Statement of Financial Position [Abstract] | ||
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 4,009,288 | 3,039,943 |
Common stock, shares outstanding | 4,009,288 | 3,039,943 |
Consolidated Statements of Loss
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | ||
Income Statement [Abstract] | |||||
REVENUE | $ 1,990,737 | $ 3,734,322 | $ 9,197,101 | $ 18,649,715 | |
COST OF REVENUE | |||||
Cost of product and services | 2,261,864 | 3,308,857 | 8,563,090 | 14,191,705 | |
Stock written off due to natural disaster | 729,029 | 3,358,716 | |||
Business and sales related tax | 7,160 | 15,341 | 29,100 | 43,004 | |
Total cost of revenue | 2,998,053 | 3,324,198 | 11,950,906 | 14,234,709 | |
GROSS PROFIT (LOSS) | (1,007,316) | 410,124 | (2,753,805) | 4,415,006 | |
OPERATING EXPENSES | |||||
General and administrative expenses | 5,016,939 | 3,896,478 | 13,625,060 | 9,343,435 | |
Selling expenses | 32,525 | 145,526 | 86,870 | 340,681 | |
Total operating expenses | 5,049,464 | 4,042,004 | 13,711,930 | 9,684,116 | |
LOSS FROM OPERATIONS | (6,056,780) | (3,631,880) | (16,465,735) | (5,269,110) | |
OTHER INCOME (EXPENSE) | |||||
Income (loss) from equity method investments | (1,777,551) | (43,054) | (3,753,280) | 97,528 | |
Other income (expense), net | (28,076) | 627 | (2,066,268) | 39,084 | |
Interest expense, net | (452) | (7,942) | (30,977) | (8,250) | |
Total other income (expense) | (1,806,079) | (50,369) | (5,850,525) | 128,362 | |
LOSS BEFORE PROVISION FOR INCOME TAXES | (7,862,859) | (3,682,249) | (22,316,260) | (5,140,748) | |
PROVISION (BENEFIT) FOR INCOME TAXES | (83,106) | 110,177 | 274,569 | ||
NET LOSS | (7,779,753) | (3,792,426) | (22,316,260) | (5,415,317) | |
Net income (loss) attributable to non-controlling interest | (272,488) | 25,267 | (732,572) | 82,530 | |
NET LOSS ATTRIBUTABLE TO SHINECO, INC. | (7,507,265) | (3,817,693) | (21,583,688) | (5,497,847) | |
COMPREHENSIVE LOSS | |||||
Net loss | (7,779,753) | (3,792,426) | (22,316,260) | (5,415,317) | |
Other comprehensive income (loss): foreign currency translation income (loss) | (164,631) | (1,209,436) | 4,911,863 | (2,320,277) | |
Total comprehensive income loss | (7,944,384) | (5,001,862) | (17,404,397) | (7,735,594) | |
Less: comprehensive income (loss) attributable to non-controlling interest | (273,806) | 5,280 | (653,158) | 47,067 | |
COMPREHENSIVE LOSS ATTRIBUTABLE TO SHINECO, INC. | $ (7,670,578) | $ (5,007,142) | $ (16,751,239) | $ (7,782,661) | |
Weighted average number of shares basic and diluted | [1] | 3,184,593 | 3,037,048 | 3,372,327 | 2,920,086 |
Basic and diluted loss per common share | $ (2.36) | $ (1.26) | $ (6.40) | $ (1.88) | |
[1] | Retrospectively restated for effect of stock split on August 14, 2020. |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-In Capital [Member] | Statutory Reserve [Member] | Retained Earnings [Member] | Accumulated Other Comprehensive Loss [Member] | Non-Controlling Interest [Member] | Total | |
Beginning balance at Jun. 30, 2019 | $ 2,541 | $ 24,779,687 | $ 4,198,107 | $ 46,735,190 | $ (4,184,024) | $ 1,100,613 | $ 72,632,114 | |
Beginning balance, shares at Jun. 30, 2019 | [1] | 2,541,308 | ||||||
Stock issuance | $ 496 | 2,522,367 | 2,522,863 | |||||
Stock issuance, shares | [1] | 495,740 | ||||||
Net income (loss) | (5,497,847) | 82,530 | (5,415,317) | |||||
Foreign currency translation gain (loss) | (2,284,814) | (35,463) | (2,320,277) | |||||
Ending balance at Mar. 31, 2020 | $ 3,037 | 27,302,054 | 4,198,107 | 41,237,343 | (6,468,838) | 1,147,680 | 67,419,383 | |
Ending balance, shares at Mar. 31, 2020 | 3,037,048 | |||||||
Beginning balance at Dec. 31, 2019 | $ 3,037 | 27,302,054 | 4,198,107 | 45,055,036 | (5,279,389) | 1,142,400 | 72,421,245 | |
Beginning balance, shares at Dec. 31, 2019 | [1] | 3,037,048 | ||||||
Net income (loss) | (3,817,693) | 25,267 | (3,792,426) | |||||
Foreign currency translation gain (loss) | (1,189,449) | (19,987) | (1,209,436) | |||||
Ending balance at Mar. 31, 2020 | $ 3,037 | 27,302,054 | 4,198,107 | 41,237,343 | (6,468,838) | 1,147,680 | 67,419,383 | |
Ending balance, shares at Mar. 31, 2020 | 3,037,048 | |||||||
Beginning balance at Jun. 30, 2020 | $ 3,040 | 27,302,051 | 4,198,107 | 40,106,518 | (6,283,835) | 1,186,520 | 66,512,401 | |
Beginning balance, shares at Jun. 30, 2020 | [1] | 3,039,943 | ||||||
Stock issuance | $ 969 | 2,735,453 | 2,736,422 | |||||
Stock issuance, shares | [1] | 969,345 | ||||||
Net income (loss) | (21,583,688) | (732,572) | (22,316,260) | |||||
Foreign currency translation gain (loss) | 4,832,449 | 79,414 | 4,911,863 | |||||
Ending balance at Mar. 31, 2021 | $ 4,009 | 30,037,504 | 4,198,107 | 18,522,830 | (1,451,386) | 533,362 | 51,844,426 | |
Ending balance, shares at Mar. 31, 2021 | [1] | 4,009,288 | ||||||
Beginning balance at Dec. 31, 2020 | $ 3,645 | 28,944,533 | 4,198,107 | 26,030,095 | (1,288,073) | 807,168 | 58,695,475 | |
Beginning balance, shares at Dec. 31, 2020 | [1] | 3,644,843 | ||||||
Stock issuance | $ 364 | 1,092,971 | 1,093,335 | |||||
Stock issuance, shares | [1] | 364,445 | ||||||
Net income (loss) | (7,507,265) | (272,488) | (7,779,753) | |||||
Foreign currency translation gain (loss) | (163,313) | (1,318) | (164,631) | |||||
Ending balance at Mar. 31, 2021 | $ 4,009 | $ 30,037,504 | $ 4,198,107 | $ 18,522,830 | $ (1,451,386) | $ 533,362 | $ 51,844,426 | |
Ending balance, shares at Mar. 31, 2021 | [1] | 4,009,288 | ||||||
[1] | Retrospectively restated for effect of stock split on August 14, 2020. |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (22,316,260) | $ (5,415,317) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 520,005 | 891,727 |
Loss from disposal of property and equipment | 2,154,151 | 60,111 |
Provision for doubtful accounts | 11,141,211 | 5,748,507 |
Provision for inventory reserve | 216,629 | 242,015 |
Stock written off due to natural disaster | 3,358,716 | |
Deferred tax benefit | (202,293) | |
Loss (income) from equity method investments | 3,753,280 | (97,528) |
Amortization of right of use assets | 424,638 | |
Restricted shares issued for management | 1,022,661 | |
Changes in operating assets and liabilities: | ||
Accounts receivable | (2,420,160) | (1,037,487) |
Advances to suppliers | (4,332,686) | 3,268,646 |
Inventories | (3,990,001) | 209,054 |
Other receivables | (3,813,081) | (767,368) |
Prepaid expense and other assets | 4,450 | 441,640 |
Due from related parties | 62,570 | |
Right of use assets | (32,376) | |
Accounts payable | 116,677 | (52,865) |
Advances from customers | (367,705) | |
Other payables | 3,641,524 | 293,804 |
Operating lease liabilities | (11,513) | |
Taxes payable | (301,821) | 29,733 |
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | (11,854,241) | 4,297,529 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Acquisitions of property and equipment | (1,497) | |
Proceeds from disposal of property and equipment | 1,497,675 | 79,414 |
Proceeds from withdrawal of investments | 1,027,405 | |
Repayments (advances) of loans to third parties | (1,273,024) | 38,377 |
NET CASH PROVIDED BY INVESTING ACTIVITIES | 1,252,056 | 116,294 |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from short-term loans | 299,535 | 2,352,488 |
Repayment of short-term loans | (973,489) | (2,352,488) |
Repayment of other short-term loans | (7,129) | |
Proceeds from issuance of common stock | 2,736,422 | 1,500,203 |
Proceeds from (repayments of) advances from related parties | (297,510) | 614,526 |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 1,764,958 | 2,107,600 |
EFFECT OF EXCHANGE RATE CHANGE ON CASH | 2,314,452 | (1,206,310) |
NET INCREASE (DECREASE) IN CASH | (6,522,775) | 5,315,113 |
CASH - Beginning of the Period | 32,371,372 | 35,330,676 |
CASH - End of the Period | 25,848,597 | 40,645,789 |
SUPPLEMENTAL CASH FLOW DISCLOSURES: | ||
Cash paid for income taxes | 619,704 | 530,299 |
Cash paid for interest | 88,894 | 84,432 |
SUPPLEMENTAL NON-CASH OPERATING ACTIVITY: | ||
Right-of-use assets obtained in exchange for operating lease obligations | $ 413,955 |
Organization and Nature of Oper
Organization and Nature of Operations | 9 Months Ended |
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Nature of Operations | NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS Shineco, Inc. (“Shineco” or the “Company”) was incorporated in the State of Delaware on August 20, 1997. The Company is a holding company whose primary purpose is to develop business opportunities in the People’s Republic of China (the “PRC” or “China”). On December 30, 2004, the Company acquired all of the issued and outstanding shares of Beijing Tenet-Jove Technological Development Co., Ltd. (“Tenet-Jove”), a PRC company, in exchange for restricted shares of the Company’s common stock, and the sole operating business of the Company became that of its subsidiary, Tenet-Jove. Tenet-Jove was incorporated on December 15, 2003 under the laws of China. Consequently, Tenet-Jove became a 100% owned subsidiary of Shineco and was officially granted the status of a wholly foreign-owned entity by Chinese authorities on July 14, 2006. This transaction was accounted for as a recapitalization. Tenet-Jove owns 90% interest of Tianjin Tenet Huatai Technological Development Co., Ltd. (“Tenet Huatai”). On December 31, 2008, June 11, 2011, and May 24, 2012, Tenet-Jove entered into a series of contractual agreements including an Executive Business Cooperation Agreement, a Timely Reporting Agreement, an Equity Interest Pledge Agreement, and an Executive Option Agreement (collectively, the “VIE Agreements”), with each one of the following entities, Ankang Longevity Pharmaceutical (Group) Co., Ltd. (“Ankang Longevity Group”), Yantai Zhisheng International Freight Forwarding Co., Ltd. (“Zhisheng Freight”), Yantai Zhisheng International Trade Co., Ltd. (“Zhisheng Trade”), Yantai Mouping District Zhisheng Agricultural Produce Cooperative (“Zhisheng Agricultural”), and Qingdao Zhihesheng Agricultural Produce Services., Ltd. (“Qingdao Zhihesheng”). On February 24, 2014, Tenet-Jove entered into the same series of contractual agreements with Shineco Zhisheng (Beijing) Bio-Technology Co., Ltd. (“Zhisheng Bio-Tech”), which was incorporated in 2014. Zhisheng Bio-Tech, Zhisheng Freight, Zhisheng Trade, Zhisheng Agricultural, and Qingdao Zhihesheng are collectively referred to herein as the “Zhisheng VIEs.” Pursuant to the VIE Agreements, Tenet-Jove has the exclusive right to provide to the Zhisheng VIEs and Ankang Longevity Group consulting services related to their business operations and management. All the above contractual agreements obligate Tenet-Jove to absorb a majority of the risk of loss from the Zhisheng VIEs and Ankang Longevity Group’s activities and entitle Tenet-Jove to receive a majority of their residual returns. In essence, Tenet-Jove has gained effective control over the Zhisheng VIEs and Ankang Longevity Group. Therefore, the Zhisheng VIEs and Ankang Longevity Group are treated as variable interest entities (“VIEs”) under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810 “Consolidation.” Accordingly, the accounts of these entities are consolidated with those of Tenet-Jove. Since Shineco is effectively controlled by the majority shareholders of the Zhisheng VIEs and Ankang Longevity Group, Shineco owns 100% of Tenet-Jove. Accordingly, Shineco, Tenet-Jove, and its VIEs, the Zhisheng VIEs and Ankang Longevity Group are effectively controlled by the same majority shareholders. Therefore, Shineco, Tenet-Jove, and the VIEs of Tenet-Jove are considered under common control. The consolidation of Tenet-Jove and its VIEs into Shineco was accounted for at historical cost and prepared on the basis as if the aforementioned exclusive contractual agreements between Tenet-Jove and its VIEs had become effective as of the beginning of the first period presented in the accompanying unaudited condensed consolidated financial statements. On May 2, 2017, the Company entered into a Strategic Cooperation Agreement with Beijing Zhongke Biorefinery Engineering Technology Co., Ltd. (“Biorefinery”), a leading high-tech biomass refining company financially backed by the Chinese Academy of Sciences Institute of Process Engineering, to establish the Institute of Chinese Apocynum Industrial Technology Research (“ICAITR”). Pursuant to the Strategic Cooperation Agreement, the two parties agreed to establish the ICAITR, with the Company and Biorefinery owning 80% and 20% of the equity interests of ICAITR, respectively. Shineco invested RMB5.0 million (US$737,745) as the registered capital, and Biorefinery would invest a technology patent named “Steam Explosion Degumming.” On September 30, 2017, Tenet-Jove established Xinjiang Shineco Taihe Agriculture Technology Ltd. (“Xinjiang Taihe”) with registered capital of RMB10.0 million (US$1,502,650). On September 30, 2017, Tenet-Jove established Xinjiang Tianyi Runze Bioengineering Co., Ltd. (“Runze”) with registered capital of RMB10.0 million (US$1,502,650). Xinjiang Taihe and Runze became wholly-owned subsidiaries of Tenet-Jove. On December 10, 2016, Tenet-Jove entered into a purchase agreement with Tianjin Tajite E-Commerce Co., Ltd. (“Tianjin Tajite”), an online e-commerce company based in Tianjin, China, specializing in distributing Luobuma related products and branded products of Daiso 100-yen shops, pursuant to which Tenet-Jove would acquire a 51% equity interest in Tianjin Tajite for cash consideration of RMB14,000,000 (approximately US$2.1 million). On December 25, 2016, the Company paid the full amount as the deposit to secure the deal. In May, 2017, the Company amended the agreement and required Tianjin Tajite to satisfy certain preconditions related to product introductions into China. On October 26, 2017, the Company completed the acquisition for 51% of the shares in Tianjin Tajite. On October 27, 2017, the Company, through its subsidiary Tianjin Tajite, obtained contractual rights to distribute branded products of Daiso Industries Co., Ltd. (“Daiso”), a large franchise of 100-yen shops founded in Japan, via JD.com, one of the largest e-commerce companies and one of the largest retailers in China. On November 3, 2017, the Company further developed the cooperation with Daiso by entering into a supply and purchase agreement (the “Daiso Agreement”) for the purpose of establishing a continuous supply and sale of Daiso’s products in China. Pursuant to the Daiso Agreement, the Company planned to purchase Daiso Products in the amount of approximately RMB20 million by August 2018 and add orders as circumstance requires. The term of the Daiso Agreement is for one year, and it renews for an additional one-year at the end of each term unless terminated by written notice by either Tianjin Tajite or Daiso. Due to the policy of China Customs, many of the bestselling products of Daiso are not allowed to be imported through the general form of trade model, but only through cross-border e-commence business model. As a result, the Company and Daiso agreed to suspend the cooperation temporarily and wait for the opening of the China-Japan-South Korea Free Trade Zone. On November 1, 2017, the Company established an Apocynum Industrial Park in Xinjiang, China. The industrial park is focusing on planting and purchasing Bluish Dogbane and processing and distributing Bluish Dogbane preliminary products. On March 13, 2019, Tenet-Jove established Beijing Tenjove Newhemp Biotechnology Co., Ltd. (“TNB”) with registered capital of RMB10.0 million (US$1,502,650). TNB became a wholly-owned subsidiary of Tenet-Jove. On August 22, 2019, Tenet-Jove established Shineco Zhong Hemp Group Co., Ltd. (“Zhong Hemp”) with registered capital of RMB200.0 million (US$28,237,022) and owns 60% interest of Zhong Hemp. We ceased the business operation of Xinjiang Taihe and Runze in September 2020 and October 2020, respectively. The Company, its subsidiaries, its VIEs, and its VIEs’ subsidiaries (collectively the “Group”) operate three main business segments: 1) Tenet-Jove is engaged in manufacturing and selling Bluish Dogbane and related products, also known in Chinese as “Luobuma,” including therapeutic clothing and textile products made from Luobuma; 2) the Zhisheng VIEs are engaged in planting, processing, and distributing green agricultural produce as well as providing domestic and international logistic services for agricultural products (“Agricultural Products”); and, 3) Ankang Longevity Group manufactures traditional Chinese medicinal herbal products as well as other retail pharmaceutical products. These different business activities and products can potentially be integrated and benefit from one another. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules of the SEC and have been consistently applied. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for the full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended June 30, 2020, which was filed on September 28, 2020. The unaudited condensed consolidated financial statements of the Company reflect the principal activities of the Company, its subsidiaries, its VIEs, and its VIEs’ subsidiaries. The non-controlling interest represents the minority shareholders’ interest in the Company’s majority owned subsidiaries and VIEs. All intercompany accounts and transactions have been eliminated in consolidation. Consolidation of Variable Interest Entities VIEs are generally entities that lack sufficient equity to finance their activities without additional financial support from other parties or whose equity holders lack adequate decision-making ability. All VIEs and their subsidiaries with which the Company is involved must be evaluated to determine the primary beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting purposes. The carrying amount of the VIEs and their subsidiaries’ consolidated assets and liabilities and income information were as follows: March 31, 2021 June 30, 2020 Current assets $ 52,240,926 $ 58,350,565 Plant and equipment, net 4,679,535 8,168,594 Other non-current assets 4,369,823 11,054,954 Total assets 61,290,284 77,574,113 Total liabilities (7,046,069 ) (6,189,172 ) Net assets $ 54,244,215 $ 71,384,941 For the nine months ended For the three months ended 2021 2020 2021 2020 Net sales $ 9,115,071 $ 18,565,197 $ 1,971,082 $ 3,731,867 Gross profit (loss) $ (2,562,654 ) $ 4,620,187 $ (873,783 ) $ 484,907 Loss from operations $ (14,234,577 ) $ (1,054,684 ) $ (5,119,542 ) $ (2,805,273 ) Net loss $ (19,443,845 ) $ (1,323,411 ) $ (6,591,598 ) $ (3,030,057 ) Non-controlling Interests U.S. GAAP requires that non-controlling interests in subsidiaries and affiliates be reported in the equity section of a company’s balance sheet. In addition, the amounts attributable to the non-controlling interests in the net income of these entities are reported separately in the unaudited condensed consolidated statements of loss and comprehensive loss. Risks and Uncertainties The operations of the Company are located in the PRC and are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic, and legal environment and foreign currency exchange. The Company’s results may be adversely affected by changes in the political, regulatory, and social conditions in the PRC, and by changes in governmental policies or interpretations with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation, among other things. Although the Company has not experienced losses from these factors and believes that it is in compliance with existing laws and regulations, there is no guarantee that the Company will continue to do so in the future. Members of the current management team own controlling interests in the Company and are also the owners of the VIEs in the PRC. The Company only controls the VIEs through contractual arrangements, which obligate it to absorb the risk of loss and to receive the residual expected returns. As such, the controlling shareholders of the Company and the VIEs could cancel these agreements or permit them to expire at the end of the agreement terms, as a result of which the Company would not retain control of the VIEs. In addition, should these agreements be challenged or litigated, they would also be subject to the laws and courts of the PRC legal system, which could make enforcing the Company’s rights difficult. Use of Estimates The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements as well as the reported amounts of revenue and expenses during the reporting periods. Significant estimates required to be made by management include, but are not limited to, useful lives of property, plant, and equipment, and intangible assets, the recoverability of long-lived assets, and the valuation of accounts receivable, deferred taxes, and inventory reserves. Actual results could differ from those estimates. Revenue Recognition The Company previously recognized revenue from sales of Luobuma products, Chinese medicinal herbal products, and agricultural products, as well as providing logistic services and other processing services to external customers. The Company recognized revenue when all of the following have occurred: (i) there was persuasive evidence of an arrangement with a customer; (ii) delivery had occurred or services had been rendered; (iii) the sales price was fixed or determinable; and (iv) the Company’s collection of such fees was reasonably assured. These criteria, as related to the Company’s revenue, were considered to have been met as follows: Sales of products: Revenue from the provision of services With the adoption of ASC 606, “Revenue from Contracts with Customers,” revenue is recognized when all of the following five steps are met: (i) identify the contract(s) with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations; (v) recognize revenue when (or as) each performance obligation is satisfied. The Company adopted the new revenue standard beginning July 1, 2018, and adopted a modified retrospective approach upon adoption. The Company believes that its previous revenue recognition policies are generally consistent with the new revenue recognition standards set forth in ASC 606. Potential adjustments to input measures are not expected to be pervasive to the majority of the Company’s contracts. There is no significant impact upon adoption of the new guidance. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, cash on deposit, and other highly liquid investments which are unrestricted as to withdrawal or use, and which have original maturities of three months or less when purchased. The Company maintains cash with various financial institutions mainly in the PRC. As of March 31, 2021 and June 30, 2020, the Company had no cash equivalents. Under PRC law, it is generally required that a commercial bank in the PRC that holds third-party cash deposits protect the depositors’ rights over and interests in their deposited money. PRC banks are subject to a series of risk control regulatory standards, and PRC bank regulatory authorities are empowered to take over the operation and management of any PRC bank that faces a material credit crisis. The Company monitors the banks utilized and has not experienced any problems. Accounts Receivable, Net Accounts receivable are recorded at net realizable value, consisting of the carrying amount less an allowance for uncollectible accounts, as necessary. The Company reviews the accounts receivable on a periodic basis and makes general and specific allowances when there is doubt as to the collectability of individual balances. In evaluating the collectability of individual receivable balances, the Company considers many factors, including the age of the balance, the customers’ historical payment history, their current credit-worthiness, and current economic trends. The fair value of long-term receivables is determined using a present value technique by discounting the future expected contractual cash flows using current rates at which similar instruments would be issued at the measurement date. As of March 31, 2021 and June 30, 2020, the allowance for doubtful accounts was US$13,539,904 and US$5,235,436, respectively. Accounts are written off against the allowance after efforts at collection prove unsuccessful. Inventories, Net Inventories, which are stated at the lower of cost or net realizable value, consist of raw materials, work-in-progress, and finished goods related to the Company’s products. Cost is determined using the first in first out (“FIFO”) method. Agricultural products that the Company farms are recorded at cost, which includes direct costs such as seed selection, fertilizer, labor cost and contract fees that are spent in growing agricultural products on the leased farmland, and indirect costs which include amortization of prepayments of farmland leases and farmland development costs. All the costs are accumulated until the time of harvest and then allocated to the harvested crops costs when they are sold. The Company periodically evaluates its inventory and records an inventory reserve for certain inventories that may not be saleable or whose cost exceeds net realizable value. As of March 31, 2021 and June 30, 2020, the inventory reserve was US$1,429,804 and US$1,121,408, respectively. Advances to Suppliers, Net Advances to suppliers consist of payments to suppliers for materials that have not been received. Advances to suppliers are reviewed periodically to determine whether their carrying value has become impaired. As of March 31, 2021 and June 30, 2020, the Company had an allowance for uncollectible advances to suppliers of US$5,629,606 and US$3,342,590, respectively. Business Acquisitions Business acquisitions are accounted for under the acquisition method. The acquisition method requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquired entity, and recognize and measure goodwill or a bargain gain from the purchase. The acquiree’s results are included in the Company’s consolidated financial statements from the date of acquisition. Assets acquired and liabilities assumed are recorded at their fair values on the date acquired and the excess of the purchase price over the amounts assigned is recorded as goodwill, or if the fair value of the net assets acquired exceeds the purchase price consideration, a bargain purchase gain is recorded. Adjustments to fair value assessments are generally recorded to goodwill over the measurement period (not longer than 12 months). The acquisition method also requires that acquisition-related transaction and post-acquisition restructuring costs be charged to expense as committed, and requires the Company to recognize and measure certain assets and liabilities, including those arising from contingencies and contingent consideration in a business combination. Goodwill Goodwill represents the excess of the purchase price over the fair value of assets acquired. The goodwill impairment test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, goodwill of the reporting unit would be considered impaired. To measure the amount of the impairment loss, the implied fair value of a reporting unit’s goodwill is compared to the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. For each of these tests, the fair value of each of the Company’s reporting units is determined using a combination of valuation techniques, including a discounted cash flow methodology. To corroborate the discounted cash flow analysis performed at each reporting unit, a market approach is utilized using observable market data such as comparable companies in similar lines of business that are publicly traded or which are part of a public or private transaction (to the extent available). Leases The Company adopted ASU 2016-02, “Leases” on July 1, 2019 and used the alternative transition approach, which permits the effects of adoption to be applied at the effective date. The new standard provides a number of optional practical expedients in transition. The Company elected the “package of practical expedients,” which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. The Company also elected the short-term lease exemption and combining the lease and non-lease components practical expedients. The most significant impact upon adoption relates to the recognition of new Right-of-use (“ROU”) assets and lease liabilities on the Company’s balance sheet for office space operating leases. Upon adoption, the Company recognized additional operating liabilities of approximately US$0.5 million, with corresponding ROU assets of US$3.6 million based on the present value of the remaining rental payments under current leasing standards for existing operating leases. There was no cumulative effect of adopting the standard. Property and Equipment, Net Property and equipment are stated at cost, less accumulated depreciation and amortization. Expenditures for additions, major renewals, and betterments are capitalized, and expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is provided on a straight-line basis, less estimated residual value, if any, over an asset’s estimated useful life. Farmland leasehold improvements are amortized over the shorter of lease term or estimated useful lives of the underlying assets. The estimated useful lives of the Company’s property and equipment are as follows: Estimated useful lives Buildings 20-50 years Machinery equipment 5-10 years Motor vehicles 5-10 years Office equipment 5-10 years Farmland leasehold improvements 12-18 years Land Use Rights, Net According to Chinese laws and regulations regarding land use rights, land in urban districts is owned by the state, while land in the rural areas and suburban areas, except otherwise provided for by the state, is collectively owned by individuals designated as resident farmers by the state. In accordance with the legal principle that land ownership is separate from the right to the use of the land, the government grants individuals and companies the rights to use parcels of land for a specified period of time. Land use rights, which are usually prepaid, are stated at cost less accumulated amortization. Amortization is provided over the life of the land use rights, using the straight-line method. The useful life is 50 years, based on the term of the land use rights. Long-lived Assets Finite-lived assets and intangibles are reviewed for impairment testing when circumstances require. For purposes of evaluating the recoverability of long-lived assets, when undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value. The long-lived assets of the Company that are subject to evaluation consist primarily of property, plant and equipment, land use rights, investments, and long-term prepaid leases. For the nine and three months ended March 31, 2021 and 2020, the Company did not recognize any impairment of its long-lived assets. Fair Value of Financial Instruments The Company follows the provisions of ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 applies to assets or liabilities for which there are inputs, other than quoted prices in level, that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the asset or liability. The carrying value of financial instruments included in current assets and liabilities approximate their fair values because of the short-term nature of these instruments. Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provisions of ASC 740-10-25, “Accounting for Uncertainty in Income Taxes,” prescribe a more-likely-than-not threshold for unaudited condensed consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This ASC also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures. The Company did not have any uncertain tax positions at March 31, 2021 and June 30, 2020. The Company had not provided deferred taxes for undistributed earnings of non-U.S. subsidiaries at March 31, 2021, as it is the Company’s policy to indefinitely reinvest these earnings in non-U.S. operations. Quantification of the deferred tax liability, if any, associated with indefinitely reinvested earnings is not practicable. The statute of limitations for the Company’s U.S. federal income tax returns and certain state income tax returns remains open for tax year 2017 and thereafter. As of March 31, 2021, the tax years ended December 31, 2016 through December 31, 2020 for the Company’s PRC subsidiaries remained open for statutory examination by PRC tax authorities. On December 22, 2017, the “Tax Cuts and Jobs Act” (“The Act”) was enacted. Under the provisions of The Act, the U.S. corporate tax rate decreased from 35% to 21%. As the Company has a June 30 fiscal year end, the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal rate of approximately 28% for our fiscal year ended June 30, 2018, and 21% for subsequent fiscal years. Additionally, The Act imposes a one-time transition tax on deemed repatriation of historical earnings of foreign subsidiaries, and future foreign earnings are subject to U.S. taxation. The change in rate caused the Company to re-measure its income tax liability and record an estimated income tax expense of US$744,766 for the year ended June 30, 2018. On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of The Act. In accordance with SAB 118, additional work is necessary to do a more detailed analysis of The Act as well as potential correlative adjustments. Any subsequent adjustment to these amounts will be recorded to current tax expense in fiscal 2019 when the analysis is complete. The Company elects to pay the transition tax over an eight-year period using specified percentages (eight percent per year for the first five years, 15 percent in year six, 20 percent in year seven, and 25 percent in year eight). Value-Added Tax Sales revenue represents the invoiced value of goods, net of a value-added tax (“VAT”). Before May 1, 2018, all of the Company’s products that were sold in the PRC were subject to a Chinese value-added tax at a rate of 17% of the gross sales price. After May 1, 2018, the Company was subject a tax rate of 16%, and after April 1, 2019, the tax rate was further reduced to 13% based on the new Chinese tax law. This VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing finished products or acquiring finished products. The Company records a VAT payable or VAT receivable in the accompanying unaudited condensed consolidated financial statements. Foreign Currency Translation The Company uses the United States dollar (“U.S. dollars,” “USD,” or “US$”) for financial reporting purposes. The Company’s subsidiaries and VIEs maintain their books and records in their functional currency of Renminbi (“RMB”), the currency of the PRC. In general, for consolidation purposes, the Company translates the assets and liabilities of its subsidiaries and VIEs into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statements of income and cash flows are translated at average exchange rates during the reporting periods. As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the financial statements of the subsidiaries and VIEs are recorded as accumulated other comprehensive loss. The balance sheet amounts, with the exception of equity, at March 31, 2021 and June 30, 2020 were translated at 1 RMB to 0.1525 USD and at 1 RMB to 0.1414 USD, respectively. The average translation rates applied to the income and cash flow statement amounts for the nine months ended March 31, 2021 and 2020 were 1 RMB to 0.1498 USD and 1 RMB to 0.1426 USD, respectively. The average translation rates applied to income and cash flow statement amounts for the three months ended March 31, 2021 and 2020 were 1 RMB to 0.1542 USD and 1 RMB to 0.1432 USD, respectively. Comprehensive Loss Comprehensive loss consists of two components, net loss and other comprehensive income (loss). The foreign currency translation gain or loss resulting from translation of the financial statements expressed in RMB to USD is reported in other comprehensive income (loss) in the unaudited condensed consolidated statements of loss and comprehensive loss. Equity Investment An investment in which the Company has the ability to exercise significant influence, but does not have a controlling interest, is accounted for using the equity method. Significant influence is generally considered to exist when the Company has an ownership interest in the voting stock between 20% and 50%, and other factors, such as representation on the board of directors, voting rights, and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Loss per Share The Company computes loss per share (“EPS”) in accordance with ASC 260, “Earnings per Share” (“ASC 260”). ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net loss divided by the weighted average common shares outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common shares (e.g., outstanding convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. There is no anti-dilutive effect for the nine and three months ended March 31, 2021 and 2020. New Accounting Pronouncements In November 2019, the FASB issued ASU No. 2019-08, Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606). The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that ASU expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. For entities that have adopted the amendments in Update 2018-07, the updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company adopted this ASU on July 1, 2020 and the adoption of this ASU did not have a material impact on its financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes. The FASB is issuing this Update as part of its initiative to reduce complexity in accounting standards (the “Simplification Initiative”). The objective of the Simplification Initiative is to identify, evaluate, and improve areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The specific areas of potential simplification in this ASU were submitted by stakeholders as part of the Simplification Initiative. For public business entities, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company expects that the adoption of this ASU will not have a material impact on its financial statements. In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, (“ASU 2020-03”). ASU 2020-03 improves various financial instruments topics, including the CECL Standard. ASU 2020-03 includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of ASU 2020-03. The amendments related to Issue 3, Issue 6, and Issue 7 were effective for the Company beginning on January 1, 2020. The Company adopted this ASU on July 1, 2020 and the adoption of this ASU did not have a material impact on its financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments in this standard can be applied anytime between the first quarter of 2020 and the fourth quarter of 2022. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows, and disclosures. The Company believes that other recent accounting pronouncement updates will not have a material effect on the Company’s condensed unaudited consolidated financial statements. |
Inventories, Net
Inventories, Net | 9 Months Ended |
Mar. 31, 2021 | |
Inventory Disclosure [Abstract] | |
Inventories, Net | NOTE 3 – INVENTORIES, NET The inventories, net consisted of the following: March 31, 2021 June 30, 2020 Raw materials $ 298,414 $ 958,206 Work-in-process 1,757,429 529,655 Finished goods 1,737,011 1,433,423 Less: inventory reserve (1,429,804 ) (1,121,408 ) Total inventories, net $ 2,363,050 $ 1,799,876 Work-in-process includes direct costs such as seed selection, fertilizer, labor cost, and subcontractor fees that are spent in growing agricultural products on the leased farmland, and indirect costs which include amortization of the prepayment of the farmland lease fees and farmland development costs. All the costs are accumulated until the time of harvest and then allocated to harvested crop costs when they are sold. |
Property and Equipment, Net
Property and Equipment, Net | 9 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | NOTE 4 - PROPERTY AND EQUIPMENT, NET Property and equipment, net consisted of the following: March 31, 2021 June 30, 2020 Buildings $ 8,157,093 $ 11,525,458 Machinery and equipment 927,978 860,610 Motor vehicles 62,141 57,630 Office equipment 249,272 231,174 Farmland leasehold improvements 3,207,353 2,974,508 12,603,837 15,649,380 Less: accumulated depreciation and amortization (6,544,912 ) (6,159,896 ) Total property and equipment, net $ 6,058,925 $ 9,489,484 Depreciation and amortization expense charged to operations was US$446,236 and US$524,239 for the nine months ended March 31, 2021 and 2020, respectively. Depreciation and amortization expense charged to operations was US$135,511 and US$104,281 for the three months ended March 31, 2021 and 2020, respectively. Farmland leasehold improvements consisted of following: March 31, 2021 June 30, 2020 Blueberry farmland leasehold improvements $ 2,464,031 $ 2,285,149 Yew tree planting base reconstruction 276,063 256,021 Greenhouse renovation 467,259 433,338 Total farmland leasehold improvements $ 3,207,353 $ 2,974,508 |
Land Use Rights, Net
Land Use Rights, Net | 9 Months Ended |
Mar. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Land Use Rights, Net | NOTE 5 - LAND USE RIGHTS, NET Land use rights are recognized at cost less accumulated amortization. According to the Chinese laws and regulations regarding land use rights, land in urban districts is owned by the state, while land in the rural areas and suburban areas, except otherwise provided for by the state, is collectively owned by individuals designated as resident farmers by the state. However, in accordance with the legal principle that land ownership is separate from the right to the use of the land, the government grants the user a “land use right” to use the land. The Company has the land use right to use the land for 50 years and amortizes the rights on a straight-line basis over the period of 50 years. March 31, 2021 June 30, 2020 Land use rights $ 1,696,485 $ 1,573,325 Less: accumulated amortization (432,802 ) (377,382 ) Total land use rights, net $ 1,263,683 $ 1,195,943 For the nine months ended March 31, 2021 and 2020, the Company recognized amortization expenses of US$28,822 and US$27,720, respectively. For the three months ended March 31, 2021 and 2020, the Company recognized amortization expenses of US$9,840 and US$9,293, respectively. The estimated future amortization expenses are as follows: 12 months ending March 31: 2022 $ 33,930 2023 33,930 2024 33,930 2025 33,930 2026 33,930 Thereafter 1,094,033 Total $ 1,263,683 |
Distribution Rights
Distribution Rights | 9 Months Ended |
Mar. 31, 2021 | |
Distribution Rights | |
Distribution Rights | NOTE 6 - DISTRIBUTION RIGHTS The Company acquired distribution rights to distribute branded products of Daiso 100-yen shops through the acquisition of Tianjin Tajite. As this distribution right is difficult to acquire and will contribute significant revenue to Tianjin Tajite, such distribution rights were identified and valued as an intangible asset in the acquisition of Tianjin Tajite. The distribution rights, which have no expiration date, have been determined to have an indefinite life. Since the distribution rights have an indefinite life, the Company will evaluate them for impairment at least annually or earlier if determined necessary. As of March 31, 2021, the distribution rights were evaluated at RMB7,380,000 (US$1,125,603). |
Investments
Investments | 9 Months Ended |
Mar. 31, 2021 | |
Investments, All Other Investments [Abstract] | |
Investments | NOTE 7 - INVESTMENTS In 2013, Ankang Longevity Group entered into two equity investment agreements with Shaanxi Pharmaceutical Group Pai’ang Medicine Co. Ltd. (“Shaanxi Pharmaceutical Group”), a Chinese state-owned pharmaceutical enterprise, to invest a total of RMB6.8 million (approximately US$1.0 million) for a 49% equity interest in a pharmacy retail company called Shaanxi Pharmaceutical Sunsimiao Drugstores Ankang Retail Chain Co., Ltd. (“Sunsimiao Drugstores”), and a 49% equity interest in a pharmaceutical wholesale distribution company named Shaanxi Pharmaceutical Holding Group Longevity Pharmacy Co., Ltd. (“Shaanxi Longevity Pharmacy”). These two entities were incorporated to collaborate with Shaanxi Pharmaceutical Group to expand sales to regional hospitals and clinics and to establish the presence of retail pharmacies under the brand name “Sunsimiao.” The investments were accounted for using the equity method because Ankang Longevity Group has significant influence, but no control of these two entities. Ankang Longevity Group recorded a loss of US$3,753,280 and an income of US$97,528 for the nine months ended March 31, 2021 and 2020, respectively and recorded a loss of US$1,777,551 and a loss of US$43,054 for the three months ended March 31, 2021 and 2020, respectively, from the investments, which was included in “Income from equity method investments” in the unaudited condensed consolidated statements of loss and comprehensive loss. (See Note 11.) On March 5, 2021, Ankang Longevity Group entered into two equity investment transfer agreements with a third-party company to sell all of its 49% equity interest in Sunsimiao Drugstores and its 49% equity interest in Shaanxi Longevity Pharmacy for a total consideration of RMB6.86 million (approximately US$1.0 million), and the full amount had been received by March 31, 2021. Upon the transfer of these two equity investments, Ankang Longevity Group recorded a loss of US$1,748,459, which was included in the investment loss for the nine and three months ended March 31, 2021 as mentioned above. In 2013, Ankang Longevity Group entered into a supplemental agreement with Shaanxi Pharmaceutical Group. According to the supplemental agreement, new 49% equity investment companies established by Shaanxi Pharmaceutical Group and Ankang Longevity Group are required to exclusively purchase certain raw materials and drug products from Shaanxi Pharmaceutical Group. In return, Shaanxi Pharmaceutical Group has agreed to compensate Ankang Longevity Group with a purchase rebate of 7% of the total purchases made from Shaanxi Pharmaceutical Group. For the nine and three months ended March 31, 2021 and 2020, no income was recognized by Ankang Longevity Group from this supplemental agreement in addition to its 49% share of the income from the equity investment companies. On October 21, 2013, the Company, through its controlled subsidiaries, Zhisheng Freight and Zhisheng Agricultural, entered into an agreement with an unrelated third party, Zhejiang Zhen’Ai Network Warehousing Services Co., Ltd. (“Zhen’Ai Network”), and invested RMB14.5 million (approximately US$2.2 million) into Tiancang Systematic Warehousing project (“Tiancang Project”) operated by Zhen’Ai Network. The Tiancang Project is an online platform established to provide comprehensive warehousing and logistic solutions to companies involved in E-commerce. The Company is entitled to 29% of Tiancang Project’s after-tax net income annually, less 30% statutory reserve and a 10% employee welfare fund contribution. When the amount of the accumulated statutory reserve reaches 30% of the total investment for the Tiancang Project, no additional appropriation to the statutory reserve is required. The Company considered it unlikely to obtain any investment income in the future, and decided to make a full impairment on this investment during the year ended June 30, 2020. The Company’s investments in unconsolidated entities consist of the following: March 31, 2021 June 30, 2020 Shaanxi Pharmaceutical Holding Group Longevity Pharmacy Co., Ltd. $ - $ 3,690,419 Shaanxi Pharmaceutical Sunsimiao Drugstores Ankang Chain Co., Ltd. - 824,705 Total investment $ - $ 4,515,124 Summarized financial information of unconsolidated entities is as follows: March 31, 2021 June 30, 2020 Current assets $ - $ 38,546,879 Noncurrent assets - 324,725 Current liabilities - 29,671,104 For the nine months ended March 31, 2021 2020 Net sales $ 21,199,520 $ 23,490,467 Gross profit 1,748,858 2,236,670 Income (loss) from operations (4,065,801 ) 195,147 Net income (loss) (4,091,472 ) 199,037 |
Leases
Leases | 9 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Leases | NOTE 8 - LEASES Effective July 1, 2019, the Company adopted the new lease accounting standard using the optional transition method, which allowed it to continue to apply the guidance under the lease standard in effect at the time in the comparative periods presented. In addition, the Company elected the package of practical expedients, which allowed it to not reassess whether any existing contracts contain a lease, to not reassess historical lease classification as operating or finance leases, and to not reassess initial direct costs. The Company has not elected the practical expedient to use hindsight to determine the lease term for its leases at transition. The Company has also elected the practical expedient, allowing it to not separate the lease and non-lease components for all classes of underlying assets. Adoption of this standard resulted in the recording of operating lease ROU assets and corresponding operating lease liabilities of $3,587,788 and $450,123, respectively, as of July 1, 2019 with no impact on accumulated deficit. Financial position for reporting periods beginning on or after July 1, 2019, are presented under the new guidance, while prior-period amounts are not adjusted and continue to be reported in accordance with previous guidance. The Company leases offices space under non-cancelable operating leases, with terms ranging from one to six years. In addition, the Zhisheng VIEs entered into several farmland lease contracts with farmer cooperatives to lease farmland in order to plant and grow organic vegetables, fruit, and Chinese yew trees. The lease terms vary from five years to 24 years. The Company considers those renewal or termination options that are reasonably certain to be exercised in the determination of the lease term and initial measurement of ROU assets and lease liabilities. Lease expenses for lease payment are recognized on a straight-line basis over the lease term. Leases with initial terms of 12 months or less are not recorded on the balance sheet. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The table below presents the operating lease related assets and liabilities recorded on the balance sheets. March 31, 2021 June 30, 2020 ROU lease assets $ 3,022,178 $ 3,227,895 Operating lease liabilities – current 97,560 97,633 Operating lease liabilities – non-current 449,162 401,891 Total operating lease liabilities $ 546,722 $ 499,524 The weighted average remaining lease terms and discount rates for all of operating leases were as follows as of March 31, 2021 and June 30, 2020: March 31, 2021 June 30, 2020 Remaining lease term and discount rate: Weighted average remaining lease term (years) 9.21 9.26 Weighted average discount rate 5.0 5.0 Rent expenses totaled US$337,128 and US$307,503 for the nine months ended March 31, 2021 and 2020, respectively. Rent expenses totaled US$112,171 and US$106,175 for the three months ended March 31, 2021 and 2020, respectively. The following is a schedule, by years, of maturities of lease liabilities as of March 31, 2021: Remainder of 2021 $ 112,118 2022 343,437 2023 341,200 2024 341,200 2025 341,200 Thereafter 1,603,424 Total lease payments 3,082,579 Less: imputed interest (60,398 ) Less: prepayments (2,475,459 ) Present value of lease liabilities $ 546,722 |
Short-Term Loans
Short-Term Loans | 9 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Short-Term Loans | NOTE 9 - SHORT-TERM LOANS Short-term loans consisted of the following: Lender March 31, 2021 Maturity Date Int. Rate/Year Agricultural Bank of China-a^ 1,525,208 2022/2/27 5.66 % Agricultural Bank of China-b 305,041 2021/9/1 5.66 % Total short-term loans $ 1,830,249 Lender June 30, 2020 Maturity Date Int. Rate/Year Agricultural Bank of China-b* $ 282,896 2020-8-22 5.60 % Agricultural Bank of China-a 636,517 2020-12-23 4.65 % Agricultural Bank of China-a 1,414,481 2021-2-24 5.66 % Total short-term loans $ 2,333,894 The loans outstanding were guaranteed by the following properties, entities or individuals: a. Guaranteed by a commercial credit guaranty company unrelated to the Company and also by Jiping Chen, a stockholder of the Company. b. Collateralized by the building owned by Xiaoyan Chen and Jing Chen, who are both related parties of the Company. Xiaoyan Chen is one of the shareholders of Ankang Longevity Group. Jing Chen is the sister of Xiaoyan Chen but not a shareholder of Ankang Longevity Group. * The Company repaid the loan in full on maturity date. ^ Upon the original maturity date of February 27, 2021, the Company signed two loan extension agreements with Agricultural Bank of China to extend the loan repayment date to February 27, 2022 with the same interest rate of 5.66% per annum. The Company recorded interest expenses of US$88,894 and US$84,432 for the nine months ended 2021 and 2020, respectively. The annual weighted average interest rates were 5.36% and 5.03% for the nine months ended 2021 and 2020, respectively. The Company recorded interest expenses of US$25,627 and US$26,166 for the three months ended 2021 and 2020, respectively. The annual weighted average interest rates were 5.50% and 4.53% for the three months ended 2021 and 2020, respectively. |
Acquisition
Acquisition | 9 Months Ended |
Mar. 31, 2021 | |
Business Combinations [Abstract] | |
Acquisition | NOTE 10 - ACQUISITION On December 12, 2016, the Company entered into a merger and acquisition agreement with Tianjin Tajite, a professional e-commerce company distributing Luobuma fabric commodities and branded products of Daiso 100-yen shops, based in Tianjin, China, to acquire 51 % equity interests in Tianjin Tajite. Pursuant to the agreement, the Company made a payment of RMB14,000,000 (approximately US$2.1 million) at the end of December 2016 as the total consideration for the acquisition of Tianjin Tajite. On October 26, 2017, the Company completed the acquisition of Tianjin Tajite. The acquisition provides a unique opportunity for the Company to enter the market of Luobuma fabric commodities and branded products of Daiso 100-yen shops. The transaction was accounted for in accordance with the provisions of ASC 805-10, Business Combinations. The Company retained independent appraisers to advise management in the determination of the fair value of the various assets acquired and liabilities assumed. The values assigned in these financial statements represents management’s best estimate of fair values as of the acquisition date. As required by ASC 805-20, Business Combinations—Identifiable Assets and Liabilities, and Any Noncontrolling Interest, management conducted a review to reassess whether they identified all the assets acquired and all the liabilities assumed, and followed ASC 805-20’s measurement procedures for recognition of the fair value of net assets acquired. The excess of the purchase price over the aggregate fair value of assets acquired was allocated to goodwill which amounted to RMB14,010,195 (approximately US$2.1 million). The results of operations of Tianjin Tajite have been included in the consolidated statements of operations from the date of acquisition. In June 2018, the management performed evaluation on the impairment of goodwill. Due to the lower than expected revenue and profit, and unfavorable business environment, the management fully recorded an impairment loss on goodwill of Tianjin Tajite. The fair value of distribution rights and its estimated useful lives are as follows: Preliminary Fair Value Weighted Average Useful Life (in Years) Distribution rights $ 1,125,603 (a) (a) The distribution rights with no expiration date has been determined to have an indefinite life. Under ASC 805-10, acquisition-related costs (i.e., advisory, legal, valuation, and other professional fees) are not included as a component of consideration transferred, but are expensed in the periods in which the costs are incurred. Acquisition-related costs were $nil in the nine and three months ended March 31, 2021. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Mar. 31, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | NOTE 11 - RELATED PARTY TRANSACTIONS Due from Related Parties The Company has made temporary advances to certain stockholders of the Company and to other entities that are either owned by family members of those stockholders or to other entities that the Company has investments in. Those advances are due on demand and non-interest bearing. As of March 31, 2021 and June 30, 2020, the outstanding amounts due from related parties consisted of the following: March 31, 2021 June 30, 2020 Yang Bin $ 45,756 $ 42,434 Beijing Huiyinansheng Asset Management Co., Ltd (a.) 22,878 21,217 Wang Qiwei 61,773 57,288 Total due from related parties $ 130,407 $ 120,939 a. This company is wholly owned by one of the Company’s senior management. Due to Related Parties As of March 31, 2021 and June 30, 2020, the Company had related party payables of US$1,131,376 and US$1,355,919, respectively, mainly due to the principal stockholders or certain relatives of the stockholders of the Company who lent funds for the Company’s operations. The payables are unsecured, non-interest bearing, and due on demand. March 31, 2021 June 30, 2020 Wu Yang $ 97,690 $ 90,598 Wang Sai 91,293 90,629 Chen Jiping - 3,024 Zhou Guocong 547,974 648,308 Li Baolin 228,781 353,619 Zhao Min 165,638 169,741 Total due to related parties $ 1,131,376 $ 1,355,919 Sales to Related Parties For the nine and three months ended March 31, 2021, the Company recorded sales to Shaanxi Pharmaceutical Group, a related party (see Note 7), of US$1,606,448 and US$311,249, respectively. For the nine and three months ended March 31, 2020, the Company recorded sales to Shaanxi Pharmaceutical Group, a related party, of US$2,128,575 and US$582,726, respectively. As of March 31, 2021 and June 30, 2020, the balance of accounts receivable due from Shaanxi Pharmaceutical Group was US$nil and US$1,567,160, respectively. |
Taxes
Taxes | 9 Months Ended |
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Taxes | NOTE 12 - TAXES (a) Corporate Income Taxes The Company is subject to income taxes on an entity basis on income arising in or derived from the location in which each entity is domiciled. Shineco is incorporated in the United States and has no operating activities. Tenet-Jove and its VIEs are governed by the Income Tax Laws of the PRC, and are currently subject to tax at a statutory rate of 25% on taxable income. Two VIEs and Xinjiang Taihe receive a full income tax exemption from the local tax authority of the PRC as agricultural enterprises as long as the favorable tax policy remains unchanged. On December 22, 2017, The Act was enacted. The Act imposes a one-time transition tax on deemed repatriation of historical earnings of foreign subsidiaries, and future foreign earnings are subject to U.S. taxation. The change in rate has caused the Company to re-measure its income tax liability and record an estimated income tax expense of US$744,766 for the year ended June 30, 2018. In accordance with SAB 118, additional work is necessary to do a more detailed analysis of The Act as well as potential correlative adjustments. Any subsequent adjustment to these amounts will be recorded to current tax expense in fiscal 2019 when the analysis is complete. The Company elects to pay the transition tax over an eight-year period using specified percentages (eight percent per year for the first five years, 15 percent in year six, 20 percent in year seven, and 25 percent in year eight). i) The components of the income tax expenses (benefits) were as follows: For the nine months ended For the three months ended 2021 2020 2021 2020 Current income tax provision (benefit) $ - $ 476,862 $ (83,106 ) $ 142,960 Deferred income tax benefit - (202,293 ) - (32,783 ) Total $ - $ 274,569 $ (83,106 ) $ 110,177 March 31, 2021 June 30, 2020 Deferred tax assets: Allowance for doubtful accounts $ 1,291,461 $ 428,879 Inventory reserve 326,903 252,022 Net operating loss carry-forwards 544,267 504,754 Total 2,162,631 1,185,655 Valuation allowance (2,162,631 ) (1,185,655 ) Total deferred tax assets - - Deferred tax liability: Distribution rights (281,401 ) (260,972 ) Total deferred tax liability (281,401 ) (260,972 ) Deferred tax liability, net $ (281,401 ) $ (260,972 Movement of the valuation allowance: March 31, 2021 June 30, 2020 Beginning balance $ 1,185,655 $ 519,671 Current year addition 884,162 680,901 Exchange difference 92,814 (14,917 ) Ending balance $ 2,162,631 $ 1,185,655 (b) Value-Added Tax The Company is subject to a VAT for selling merchandise. The applicable VAT rate was 17% before May 1, 2018 for products sold in the PRC and decreased to 16% thereafter, and after April 1, 2019, the tax rate was further reduced to 13% based on the new Chinese tax law. The amount of VAT liability is determined by applying the applicable tax rate to the invoiced amount of goods sold (output VAT) less VAT paid on purchases made with the relevant supporting invoices (input VAT). Under commercial practice in the PRC, the Company pays VAT based on tax invoices issued. The tax invoices may be issued subsequent to the date on which revenue is recognized, and there may be a considerable delay between the date on which the revenue is recognized and the date on which the tax invoice is issued. In the event that the PRC tax authorities dispute the date on which revenue is recognized for tax purposes, the PRC tax office has the right to assess a penalty based on the amount of the taxes which are determined to be late or deficient, and the penalty will be expensed in the period if and when a determination is made by the tax authorities. There were no assessed penalties during the nine and three months ended March 31, 2021 and 2020. (c) Taxes Payable Taxes payable consisted of the following: March 31, 2021 June 30, 2020 Income tax payable $ 3,326,884 $ 3,424,043 Value added tax payable 561,854 522,615 Business tax and other taxes payable 6,466 6,026 Total tax payable 3,895,204 3,952,684 Less: current portion 3,329,182 3,386,662 Income tax payable - noncurrent portion $ 566,022 $ 566,022 |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Stockholders' Equity | NOTE 13 - STOCKHOLDERS’ EQUITY Initial Public Offering On September 28, 2016, the Company completed its initial public offering of 190,354 shares of common stock at a price of US$40.50 per share for gross proceeds of US$7.7 million and net proceeds of approximately US$5.4 million. The Company’s common shares began trading on September 28, 2016 on the NASDAQ Capital Market under the symbol “TYHT.” Statutory Reserve The Company is required to make appropriations to reserve funds, comprising the statutory surplus reserve and discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (“PRC GAAP”). Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entities’ registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the board of directors. As of March 31, 2021 and June 30, 2020, the balance of the required statutory reserves was US$4,198,107 and US$4,198,107, respectively. On September 3, 2019, the Company granted 184,763 restricted shares of common stock to its employees as compensation cost for awards. The fair value of the restricted shares was US$1,022,660 based on the closing stock price US$5.54 at September 3, 2019. These restricted shares vested immediately on the grant date. On September 5, 2019, the Company entered into a securities purchase agreement with select investors whereby the Company agreed to sell, and the investors agreed to purchase, up to 310,977 shares of common stock at a purchase price of US$4.68 per Share. The Company received net proceeds of US$1,500,203. The offering was made pursuant to the Company’s effective registration statement on Form S-3 (Registration Statement No. 333-221711) previously filed with the Securities and Exchange Commission and a prospectus supplement thereunder. On July 10, 2020, the Company’s stockholders approved a 1-for-9 reverse stock split of the Company’s common stock, par value $0.001 per share, with a market effective date of August 14, 2020 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each nine pre-split shares of common stock outstanding automatically combined and converted to one issued and outstanding share of common stock without any action on the part of stockholders. No fractional shares of common stock were issued to any stockholders in connection with the Reverse Stock Split. Each stockholder was entitled to receive one share of common stock in lieu of the fractional share that would have resulted from the Reverse Stock Split. The number of the Company’s authorized common stock remained at 100,000,000 shares, and the par value of the common stock following the Reverse Stock Split remained at $0.001 per share. As of August 14, 2020 (immediately prior to the effective date), there were 27,333,428 shares of common stock outstanding, and the number of common stock outstanding after the Reverse Stock Split was 3,037,048, taking into account of the effect of rounding fractional shares into whole shares. As a result of the Reverse Stock Split, the Company’s shares and per share data as reflected in the unaudited condensed consolidated financial statements were retroactively restated as if the transaction occurred at the beginning of the periods presented. On December 10, 2020, the Company entered into a securities purchase agreement with select investors whereby the Company agreed to sell, and the investors agreed to purchase, up to 604,900 shares of common stock at a purchase price of US$2.73 per share. The Company received net proceeds of US$1,643,087. The offering was made pursuant to the Company’s effective registration statement on Form S-3 (Registration Statement No. 333-221711) previously filed with the Securities and Exchange Commission and a prospectus supplement thereunder. On January 27, 2021, the Company issued 364,445 shares of common stock to three investors at a price of US$3.0 per share. The Company received net proceeds of US$1,093,355. |
Concentrations and Risks
Concentrations and Risks | 9 Months Ended |
Mar. 31, 2021 | |
Risks and Uncertainties [Abstract] | |
Concentrations and Risks | NOTE 14 - CONCENTRATIONS AND RISKS The Company maintains principally all bank accounts in the PRC. The cash balance held in the PRC bank accounts was US$25,831,506 and US$32,358,252 as of March 31, 2021 and June 30, 2020, respectively. During the nine months ended March 31, 2021 and 2020, almost 100% of the Company’s assets were located in the PRC and 100% of the Company’s revenue was derived from its subsidiaries and VIEs located in the PRC. For the nine months ended March 31, 2021, four customers accounted for approximately 17%, 15%, 14%, and 10% of the Company’s total sales, respectively. For the three months ended March 31, 2021, three customers accounted for approximately 16%, 13%, and 12% of the Company’s total sales, respectively. At March 31, 2021, five customers accounted for approximately 72% of the Company’s accounts receivable. For the nine months ended March 31, 2020, two customers accounted for approximately 14% and 11% of the Company’s total sales, respectively. For the three months ended March 31, 2020, four customers accounted for approximately 19%, 16%, 14%, and 10% of the Company’s total sales, respectively. For the nine months ended March 31, 2021, two vendors accounted for approximately 53% and 11% of the Company’s total purchases, respectively. For the three months ended March 31, 2021, two vendors accounted for approximately 48% and 10% of the Company’s total purchases, respectively. For the nine months ended March 31, 2020, four vendors accounted for approximately 34%, 16%, 11%, and 10% of the Company’s total purchases, respectively. For the three months ended March 31, 2020, six vendors accounted for approximately 22%, 21%, 17%, 15%, 13%, and 12% of the Company’s total purchases, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 15 - COMMITMENTS AND CONTINGENCIES Legal Contingencies On May 16, 2017, Bonwick Capital Partners, LLC (the “Plaintiff”) commenced a lawsuit (Case No. 1:17-cv-03681-PGG) against the Company in the United States District Court for the Southern District of New York. Plaintiff alleged that the Company entered into an agreement with the Plaintiff, pursuant to which the Plaintiff was to provide the Company with financial advisory services in connection with the Company’s initial public offering in the United States. The Plaintiff alleged that the Company breached the Agreement and seek money damages up to US$6 million. In March 2021, the Company entered into a Settlement Agreement and Release with the Plaintiff, pursuant to which the Company paid the Plaintiff a total sum of US$ 47,500 as settlement payment, and upon acceptance of the settlement payment from the Company, the Plaintiff waived, released, and forever discharged the Company from all past and future claims. |
Segment Reporting
Segment Reporting | 9 Months Ended |
Mar. 31, 2021 | |
Segment Reporting [Abstract] | |
Segment Reporting | NOTE 16 - SEGMENT REPORTING ASC 280, “Segment Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Group’s internal organizational management structure as well as information about geographical areas, business segments, and major customers in for details on the Group’s business segments. The Company’s chief operating decision maker has been identified as the Chief Executive Officer who reviews the financial information of separate operating segments when making decisions about allocating resources and assessing performance of the Group. Based on management’s assessment, the Company has determined that it has three operating segments according to its major products and locations as follows: ● Developing, manufacturing, and distributing specialized fabrics, textile products, and other by-products derived from an indigenous Chinese plant called Apocynum Venetum, commonly known as “Bluish Dogbane” or known in Chinese as “Luobuma” (referred to herein as Luobuma): The operating companies of this segment, namely Tenet-Jove and Tenet Huatai, specialize in Luobuma growing, development and manufacturing of relevant products, as well as purchasing Luobuma raw materials processing. This segment’s operations are focused in the north region of Mainland China, mostly carried out in Beijing, Tianjin, and Xinjiang. ● Processing and distributing of traditional Chinese medicinal herbal products as well as other pharmaceutical products (“Herbal products”): The operating companies of this segment, namely AnKang Longevity Group and its subsidiaries, process more than 600 kinds of Chinese medicinal herbal products with an established domestic sales and distribution network. Ankang Longevity Group is also engaged in the retail pharmacy business and the operating revenue, which is not material, is also included in this segment. ● Planting, processing, and distributing green and organic agricultural produce as well as growing and cultivating of Chinese Yew trees (“Other agricultural products”): The operating companies of this segment, the Zhisheng VIEs, are engaged in growing and distributing green and organic vegetables and fruits as well as providing logistics services for distributing agricultural products. This segment has been focusing its efforts on the growing and cultivating of Chinese yew trees (formally known as “taxus media”), a small evergreen tree whose branches can be used for the production of medications believed to be anti-cancer and the tree itself can be used as an ornamental indoor bonsai tree, which are known to have the effect of purifying air quality. The operations of this segment are located in the East and North regions of Mainland China, mostly carried out in Shandong Province and in Beijing, where the Zhisheng VIEs have newly developed over 100 acres of modern greenhouses for cultivating yew trees and other plants. The following table presents summarized information by segment for the nine months ended March 31, 2021: For the nine months ended March 31, 2021 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 96,477 $ 6,761,663 $ 2,338,961 $ 9,197,101 Cost of revenue and related business and sales tax 287,629 5,792,488 5,870,789 11,950,906 Gross profit (loss) (191,152 ) 969,175 (3,531,828 ) (2,753,805 ) Gross profit (loss) % (198.1 )% 14.3 % (151.0 )% (29.9 )% The following table presents summarized information by segment for the nine months ended March 31, 2020: For the nine months ended March 31, 2020 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 144,659 $ 9,661,025 $ 8,844,031 $ 18,649,715 Cost of revenue and related business and sales tax 349,840 7,353,047 6,531,822 14,234,709 Gross profit (loss) (205,181 ) 2,307,978 2,312,209 4,415,006 Gross profit (loss) % (141.8 )% 23.9 % 26.1 % 23.7 % The following table presents summarized information by segment for the three months ended March 31, 2021: For the three months ended March 31, 2021 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 23,468 $ 1,352,938 $ 614,331 $ 1,990,737 Cost of revenue and related business and sales tax 157,001 1,342,583 1,498,469 2,998,053 Gross profit (loss) (133,533 ) 10,355 (884,138 ) (1,007,316 ) Gross profit (loss) % (569.0 )% 0.8 % (143.9 )% (50.6 )% The following table presents summarized information by segment for the three months ended March 31, 2020: For the three months ended March 31, 2020 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 5,900 $ 2,821,425 $ 906,997 $ 3,734,322 Cost of revenue and related business and sales tax 80,683 2,125,927 1,117,588 3,324,198 Gross profit (loss) (74,783 ) 695,498 (210,591 ) 410,124 Gross profit (loss) % (1,267.5 )% 24.7 % (23.2 )% 11.0 % Total assets as of March 31, 2021 and June 30, 2020 were as follows: March 31, 2021 June 30, 2020 Luobuma products $ 5,348,926 $ 2,836,450 Herbal products 39,467,761 43,855,815 Other agricultural products 22,774,290 32,396,346 Total assets $ 67,590,977 $ 79,088,611 |
Subsequent Events
Subsequent Events | 9 Months Ended |
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 17 - SUBSEQUENT EVENTS These unaudited condensed consolidated financial statements were approved by management and available for issuance on May 14, 2021, and the Company has evaluated subsequent events through this date. No subsequent events required adjustments to or disclosure in these unaudited condensed consolidated financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules of the SEC and have been consistently applied. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for the full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended June 30, 2020, which was filed on September 28, 2020. The unaudited condensed consolidated financial statements of the Company reflect the principal activities of the Company, its subsidiaries, its VIEs, and its VIEs’ subsidiaries. The non-controlling interest represents the minority shareholders’ interest in the Company’s majority owned subsidiaries and VIEs. All intercompany accounts and transactions have been eliminated in consolidation. |
Consolidation of Variable Interest Entities | Consolidation of Variable Interest Entities VIEs are generally entities that lack sufficient equity to finance their activities without additional financial support from other parties or whose equity holders lack adequate decision-making ability. All VIEs and their subsidiaries with which the Company is involved must be evaluated to determine the primary beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting purposes. The carrying amount of the VIEs and their subsidiaries’ consolidated assets and liabilities and income information were as follows: March 31, 2021 June 30, 2020 Current assets $ 52,240,926 $ 58,350,565 Plant and equipment, net 4,679,535 8,168,594 Other non-current assets 4,369,823 11,054,954 Total assets 61,290,284 77,574,113 Total liabilities (7,046,069 ) (6,189,172 ) Net assets $ 54,244,215 $ 71,384,941 For the nine months ended For the three months ended 2021 2020 2021 2020 Net sales $ 9,115,071 $ 18,565,197 $ 1,971,082 $ 3,731,867 Gross profit (loss) $ (2,562,654 ) $ 4,620,187 $ (873,783 ) $ 484,907 Loss from operations $ (14,234,577 ) $ (1,054,684 ) $ (5,119,542 ) $ (2,805,273 ) Net loss $ (19,443,845 ) $ (1,323,411 ) $ (6,591,598 ) $ (3,030,057 ) |
Non-controlling Interests | Non-controlling Interests U.S. GAAP requires that non-controlling interests in subsidiaries and affiliates be reported in the equity section of a company’s balance sheet. In addition, the amounts attributable to the non-controlling interests in the net income of these entities are reported separately in the unaudited condensed consolidated statements of loss and comprehensive loss. |
Risks and Uncertainties | Risks and Uncertainties The operations of the Company are located in the PRC and are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic, and legal environment and foreign currency exchange. The Company’s results may be adversely affected by changes in the political, regulatory, and social conditions in the PRC, and by changes in governmental policies or interpretations with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation, among other things. Although the Company has not experienced losses from these factors and believes that it is in compliance with existing laws and regulations, there is no guarantee that the Company will continue to do so in the future. Members of the current management team own controlling interests in the Company and are also the owners of the VIEs in the PRC. The Company only controls the VIEs through contractual arrangements, which obligate it to absorb the risk of loss and to receive the residual expected returns. As such, the controlling shareholders of the Company and the VIEs could cancel these agreements or permit them to expire at the end of the agreement terms, as a result of which the Company would not retain control of the VIEs. In addition, should these agreements be challenged or litigated, they would also be subject to the laws and courts of the PRC legal system, which could make enforcing the Company’s rights difficult. |
Use of Estimates | Use of Estimates The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements as well as the reported amounts of revenue and expenses during the reporting periods. Significant estimates required to be made by management include, but are not limited to, useful lives of property, plant, and equipment, and intangible assets, the recoverability of long-lived assets, and the valuation of accounts receivable, deferred taxes, and inventory reserves. Actual results could differ from those estimates. |
Revenue Recognition | Revenue Recognition The Company previously recognized revenue from sales of Luobuma products, Chinese medicinal herbal products, and agricultural products, as well as providing logistic services and other processing services to external customers. The Company recognized revenue when all of the following have occurred: (i) there was persuasive evidence of an arrangement with a customer; (ii) delivery had occurred or services had been rendered; (iii) the sales price was fixed or determinable; and (iv) the Company’s collection of such fees was reasonably assured. These criteria, as related to the Company’s revenue, were considered to have been met as follows: Sales of products: Revenue from the provision of services With the adoption of ASC 606, “Revenue from Contracts with Customers,” revenue is recognized when all of the following five steps are met: (i) identify the contract(s) with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations; (v) recognize revenue when (or as) each performance obligation is satisfied. The Company adopted the new revenue standard beginning July 1, 2018, and adopted a modified retrospective approach upon adoption. The Company believes that its previous revenue recognition policies are generally consistent with the new revenue recognition standards set forth in ASC 606. Potential adjustments to input measures are not expected to be pervasive to the majority of the Company’s contracts. There is no significant impact upon adoption of the new guidance. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, cash on deposit, and other highly liquid investments which are unrestricted as to withdrawal or use, and which have original maturities of three months or less when purchased. The Company maintains cash with various financial institutions mainly in the PRC. As of March 31, 2021 and June 30, 2020, the Company had no cash equivalents. Under PRC law, it is generally required that a commercial bank in the PRC that holds third-party cash deposits protect the depositors’ rights over and interests in their deposited money. PRC banks are subject to a series of risk control regulatory standards, and PRC bank regulatory authorities are empowered to take over the operation and management of any PRC bank that faces a material credit crisis. The Company monitors the banks utilized and has not experienced any problems. |
Accounts Receivable, Net | Accounts Receivable, Net Accounts receivable are recorded at net realizable value, consisting of the carrying amount less an allowance for uncollectible accounts, as necessary. The Company reviews the accounts receivable on a periodic basis and makes general and specific allowances when there is doubt as to the collectability of individual balances. In evaluating the collectability of individual receivable balances, the Company considers many factors, including the age of the balance, the customers’ historical payment history, their current credit-worthiness, and current economic trends. The fair value of long-term receivables is determined using a present value technique by discounting the future expected contractual cash flows using current rates at which similar instruments would be issued at the measurement date. As of March 31, 2021 and June 30, 2020, the allowance for doubtful accounts was US$ 13,539,904 and US$ 5,235,436, respectively. Accounts are written off against the allowance after efforts at collection prove unsuccessful. |
Inventories, Net | Inventories, Net Inventories, which are stated at the lower of cost or net realizable value, consist of raw materials, work-in-progress, and finished goods related to the Company’s products. Cost is determined using the first in first out (“FIFO”) method. Agricultural products that the Company farms are recorded at cost, which includes direct costs such as seed selection, fertilizer, labor cost and contract fees that are spent in growing agricultural products on the leased farmland, and indirect costs which include amortization of prepayments of farmland leases and farmland development costs. All the costs are accumulated until the time of harvest and then allocated to the harvested crops costs when they are sold. The Company periodically evaluates its inventory and records an inventory reserve for certain inventories that may not be saleable or whose cost exceeds net realizable value. As of March 31, 2021 and June 30, 2020, the inventory reserve was US$ 1,429,804 and US$ 1,121,408, respectively. |
Advances to Suppliers, Net | Advances to Suppliers, Net Advances to suppliers consist of payments to suppliers for materials that have not been received. Advances to suppliers are reviewed periodically to determine whether their carrying value has become impaired. As of March 31, 2021 and June 30, 2020, the Company had an allowance for uncollectible advances to suppliers of US$ 5,629,606 and US$ 3,342,590, respectively. |
Business Acquisitions | Business Acquisitions Business acquisitions are accounted for under the acquisition method. The acquisition method requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquired entity, and recognize and measure goodwill or a bargain gain from the purchase. The acquiree’s results are included in the Company’s consolidated financial statements from the date of acquisition. Assets acquired and liabilities assumed are recorded at their fair values on the date acquired and the excess of the purchase price over the amounts assigned is recorded as goodwill, or if the fair value of the net assets acquired exceeds the purchase price consideration, a bargain purchase gain is recorded. Adjustments to fair value assessments are generally recorded to goodwill over the measurement period (not longer than 12 months). The acquisition method also requires that acquisition-related transaction and post-acquisition restructuring costs be charged to expense as committed, and requires the Company to recognize and measure certain assets and liabilities, including those arising from contingencies and contingent consideration in a business combination. |
Goodwill | Goodwill Goodwill represents the excess of the purchase price over the fair value of assets acquired. The goodwill impairment test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, goodwill of the reporting unit would be considered impaired. To measure the amount of the impairment loss, the implied fair value of a reporting unit’s goodwill is compared to the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. For each of these tests, the fair value of each of the Company’s reporting units is determined using a combination of valuation techniques, including a discounted cash flow methodology. To corroborate the discounted cash flow analysis performed at each reporting unit, a market approach is utilized using observable market data such as comparable companies in similar lines of business that are publicly traded or which are part of a public or private transaction (to the extent available). |
Leases | Leases The Company adopted ASU 2016-02, “Leases” on July 1, 2019 and used the alternative transition approach, which permits the effects of adoption to be applied at the effective date. The new standard provides a number of optional practical expedients in transition. The Company elected the “package of practical expedients,” which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. The Company also elected the short-term lease exemption and combining the lease and non-lease components practical expedients. The most significant impact upon adoption relates to the recognition of new Right-of-use (“ROU”) assets and lease liabilities on the Company’s balance sheet for office space operating leases. Upon adoption, the Company recognized additional operating liabilities of approximately US$ 0.5 million, with corresponding ROU assets of US$ 3.6 million based on the present value of the remaining rental payments under current leasing standards for existing operating leases. There was no cumulative effect of adopting the standard. |
Property and Equipment, Net | Property and Equipment, Net Property and equipment are stated at cost, less accumulated depreciation and amortization. Expenditures for additions, major renewals, and betterments are capitalized, and expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is provided on a straight-line basis, less estimated residual value, if any, over an asset’s estimated useful life. Farmland leasehold improvements are amortized over the shorter of lease term or estimated useful lives of the underlying assets. The estimated useful lives of the Company’s property and equipment are as follows: Estimated useful lives Buildings 20-50 years Machinery equipment 5-10 years Motor vehicles 5-10 years Office equipment 5-10 years Farmland leasehold improvements 12-18 years |
Land Use Rights, Net | Land Use Rights, Net According to Chinese laws and regulations regarding land use rights, land in urban districts is owned by the state, while land in the rural areas and suburban areas, except otherwise provided for by the state, is collectively owned by individuals designated as resident farmers by the state. In accordance with the legal principle that land ownership is separate from the right to the use of the land, the government grants individuals and companies the rights to use parcels of land for a specified period of time. Land use rights, which are usually prepaid, are stated at cost less accumulated amortization. Amortization is provided over the life of the land use rights, using the straight-line method. The useful life is 50 years, based on the term of the land use rights. |
Long-lived Assets | Long-lived Assets Finite-lived assets and intangibles are reviewed for impairment testing when circumstances require. For purposes of evaluating the recoverability of long-lived assets, when undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value. The long-lived assets of the Company that are subject to evaluation consist primarily of property, plant and equipment, land use rights, investments, and long-term prepaid leases. For the nine and three months ended March 31, 2021 and 2020, the Company did not recognize any impairment of its long-lived assets. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company follows the provisions of ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 applies to assets or liabilities for which there are inputs, other than quoted prices in level, that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the asset or liability. The carrying value of financial instruments included in current assets and liabilities approximate their fair values because of the short-term nature of these instruments. |
Income Taxes | Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provisions of ASC 740-10-25, “Accounting for Uncertainty in Income Taxes,” prescribe a more-likely-than-not threshold for unaudited condensed consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This ASC also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures. The Company did not have any uncertain tax positions at March 31, 2021 and June 30, 2020. The Company had not provided deferred taxes for undistributed earnings of non-U.S. subsidiaries at March 31, 2021, as it is the Company’s policy to indefinitely reinvest these earnings in non-U.S. operations. Quantification of the deferred tax liability, if any, associated with indefinitely reinvested earnings is not practicable. The statute of limitations for the Company’s U.S. federal income tax returns and certain state income tax returns remains open for tax year 2017 and thereafter. As of March 31, 2021, the tax years ended December 31, 2016 through December 31, 2020 for the Company’s PRC subsidiaries remained open for statutory examination by PRC tax authorities. On December 22, 2017, the “Tax Cuts and Jobs Act” (“The Act”) was enacted. Under the provisions of The Act, the U.S. corporate tax rate decreased from 35% to 21%. As the Company has a June 30 fiscal year end, the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal rate of approximately 28% for our fiscal year ended June 30, 2018, and 21% for subsequent fiscal years. Additionally, The Act imposes a one-time transition tax on deemed repatriation of historical earnings of foreign subsidiaries, and future foreign earnings are subject to U.S. taxation. The change in rate caused the Company to re-measure its income tax liability and record an estimated income tax expense of US$744,766 for the year ended June 30, 2018. On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of The Act. In accordance with SAB 118, additional work is necessary to do a more detailed analysis of The Act as well as potential correlative adjustments. Any subsequent adjustment to these amounts will be recorded to current tax expense in fiscal 2019 when the analysis is complete. The Company elects to pay the transition tax over an eight-year period using specified percentages (eight percent per year for the first five years, 15 percent in year six, 20 percent in year seven, and 25 percent in year eight). |
Value Added Tax | Value-Added Tax Sales revenue represents the invoiced value of goods, net of a value-added tax (“VAT”). Before May 1, 2018, all of the Company’s products that were sold in the PRC were subject to a Chinese value-added tax at a rate of 17% of the gross sales price. After May 1, 2018, the Company was subject a tax rate of 16%, and after April 1, 2019, the tax rate was further reduced to 13% based on the new Chinese tax law. This VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing finished products or acquiring finished products. The Company records a VAT payable or VAT receivable in the accompanying unaudited condensed consolidated financial statements. |
Foreign Currency Translation | Foreign Currency Translation The Company uses the United States dollar (“U.S. dollars,” “USD,” or “US$”) for financial reporting purposes. The Company’s subsidiaries and VIEs maintain their books and records in their functional currency of Renminbi (“RMB”), the currency of the PRC. In general, for consolidation purposes, the Company translates the assets and liabilities of its subsidiaries and VIEs into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statements of income and cash flows are translated at average exchange rates during the reporting periods. As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the financial statements of the subsidiaries and VIEs are recorded as accumulated other comprehensive loss. The balance sheet amounts, with the exception of equity, at March 31, 2021 and June 30, 2020 were translated at 1 RMB to 0.1525 USD and at 1 RMB to 0.1414 USD, respectively. The average translation rates applied to the income and cash flow statement amounts for the nine months ended March 31, 2021 and 2020 were 1 RMB to 0.1498 USD and 1 RMB to 0.1426 USD, respectively. The average translation rates applied to income and cash flow statement amounts for the three months ended March 31, 2021 and 2020 were 1 RMB to 0.1542 USD and 1 RMB to 0.1432 USD, respectively. |
Comprehensive Loss | Comprehensive Loss Comprehensive loss consists of two components, net loss and other comprehensive income (loss). The foreign currency translation gain or loss resulting from translation of the financial statements expressed in RMB to USD is reported in other comprehensive income (loss) in the unaudited condensed consolidated statements of loss and comprehensive loss. |
Equity Investment | Equity Investment An investment in which the Company has the ability to exercise significant influence, but does not have a controlling interest, is accounted for using the equity method. Significant influence is generally considered to exist when the Company has an ownership interest in the voting stock between 20% and 50%, and other factors, such as representation on the board of directors, voting rights, and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. |
Loss per Share | Loss per Share The Company computes loss per share (“EPS”) in accordance with ASC 260, “Earnings per Share” (“ASC 260”). ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net loss divided by the weighted average common shares outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common shares (e.g., outstanding convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. There is no anti-dilutive effect for the nine and three months ended March 31, 2021 and 2020. |
New Accounting Pronouncements | New Accounting Pronouncements In November 2019, the FASB issued ASU No. 2019-08, Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606). The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that ASU expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. For entities that have adopted the amendments in Update 2018-07, the updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company adopted this ASU on July 1, 2020 and the adoption of this ASU did not have a material impact on its financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes. The FASB is issuing this Update as part of its initiative to reduce complexity in accounting standards (the “Simplification Initiative”). The objective of the Simplification Initiative is to identify, evaluate, and improve areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The specific areas of potential simplification in this ASU were submitted by stakeholders as part of the Simplification Initiative. For public business entities, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company expects that the adoption of this ASU will not have a material impact on its financial statements. In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, (“ASU 2020-03”). ASU 2020-03 improves various financial instruments topics, including the CECL Standard. ASU 2020-03 includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of ASU 2020-03. The amendments related to Issue 3, Issue 6, and Issue 7 were effective for the Company beginning on January 1, 2020. The Company adopted this ASU on July 1, 2020 and the adoption of this ASU did not have a material impact on its financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments in this standard can be applied anytime between the first quarter of 2020 and the fourth quarter of 2022. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows, and disclosures. The Company believes that other recent accounting pronouncement updates will not have a material effect on the Company’s condensed unaudited consolidated financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Schedule of Consolidated Assets and Liabilities and Income Information | The carrying amount of the VIEs and their subsidiaries’ consolidated assets and liabilities and income information were as follows: March 31, 2021 June 30, 2020 Current assets $ 52,240,926 $ 58,350,565 Plant and equipment, net 4,679,535 8,168,594 Other non-current assets 4,369,823 11,054,954 Total assets 61,290,284 77,574,113 Total liabilities (7,046,069 ) (6,189,172 ) Net assets $ 54,244,215 $ 71,384,941 For the nine months ended For the three months ended 2021 2020 2021 2020 Net sales $ 9,115,071 $ 18,565,197 $ 1,971,082 $ 3,731,867 Gross profit (loss) $ (2,562,654 ) $ 4,620,187 $ (873,783 ) $ 484,907 Loss from operations $ (14,234,577 ) $ (1,054,684 ) $ (5,119,542 ) $ (2,805,273 ) Net loss $ (19,443,845 ) $ (1,323,411 ) $ (6,591,598 ) $ (3,030,057 ) |
Schedule of Estimated Useful Lives of Property and Equipment | The estimated useful lives of the Company’s property and equipment are as follows: Estimated useful lives Buildings 20-50 years Machinery equipment 5-10 years Motor vehicles 5-10 years Office equipment 5-10 years Farmland leasehold improvements 12-18 years |
Inventories, Net (Tables)
Inventories, Net (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventories, Net | The inventories, net consisted of the following: March 31, 2021 June 30, 2020 Raw materials $ 298,414 $ 958,206 Work-in-process 1,757,429 529,655 Finished goods 1,737,011 1,433,423 Less: inventory reserve (1,429,804 ) (1,121,408 ) Total inventories, net $ 2,363,050 $ 1,799,876 |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | Property and equipment, net consisted of the following: March 31, 2021 June 30, 2020 Buildings $ 8,157,093 $ 11,525,458 Machinery and equipment 927,978 860,610 Motor vehicles 62,141 57,630 Office equipment 249,272 231,174 Farmland leasehold improvements 3,207,353 2,974,508 12,603,837 15,649,380 Less: accumulated depreciation and amortization (6,544,912 ) (6,159,896 ) Total property and equipment, net $ 6,058,925 $ 9,489,484 |
Schedule of Leasehold Improvements | Farmland leasehold improvements consisted of following: March 31, 2021 June 30, 2020 Blueberry farmland leasehold improvements $ 2,464,031 $ 2,285,149 Yew tree planting base reconstruction 276,063 256,021 Greenhouse renovation 467,259 433,338 Total farmland leasehold improvements $ 3,207,353 $ 2,974,508 |
Land Use Rights, Net (Tables)
Land Use Rights, Net (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Land Use Rights | March 31, 2021 June 30, 2020 Land use rights $ 1,696,485 $ 1,573,325 Less: accumulated amortization (432,802 ) (377,382 ) Total land use rights, net $ 1,263,683 $ 1,195,943 |
Schedule of Estimated Future Amortization Expenses | The estimated future amortization expenses are as follows: 12 months ending March 31: 2022 $ 33,930 2023 33,930 2024 33,930 2025 33,930 2026 33,930 Thereafter 1,094,033 Total $ 1,263,683 |
Investments (Tables)
Investments (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Investments, All Other Investments [Abstract] | |
Schedule of Investments in Unconsolidated Entities | The Company’s investments in unconsolidated entities consist of the following: March 31, 2021 June 30, 2020 Shaanxi Pharmaceutical Holding Group Longevity Pharmacy Co., Ltd. $ - $ 3,690,419 Shaanxi Pharmaceutical Sunsimiao Drugstores Ankang Chain Co., Ltd. - 824,705 Total investment $ - $ 4,515,124 |
Schedule of Financial Information of Unconsolidated Entities | Summarized financial information of unconsolidated entities is as follows: March 31, 2021 June 30, 2020 Current assets $ - $ 38,546,879 Noncurrent assets - 324,725 Current liabilities - 29,671,104 For the nine months ended March 31, 2021 2020 Net sales $ 21,199,520 $ 23,490,467 Gross profit 1,748,858 2,236,670 Income (loss) from operations (4,065,801 ) 195,147 Net income (loss) (4,091,472 ) 199,037 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Schedule of Operating Lease Related Assets and Liabilities | The table below presents the operating lease related assets and liabilities recorded on the balance sheets. March 31, 2021 June 30, 2020 ROU lease assets $ 3,022,178 $ 3,227,895 Operating lease liabilities – current 97,560 97,633 Operating lease liabilities – non-current 449,162 401,891 Total operating lease liabilities $ 546,722 $ 499,524 |
Schedule of Weighted Average Remaining Lease Terms and Discount Rates for Operating Leases | The weighted average remaining lease terms and discount rates for all of operating leases were as follows as of March 31, 2021 and June 30, 2020: March 31, 2021 June 30, 2020 Remaining lease term and discount rate: Weighted average remaining lease term (years) 9.21 9.26 Weighted average discount rate 5.0 5.0 |
Schedule of Maturities of Lease Liabilities | The following is a schedule, by years, of maturities of lease liabilities as of March 31, 2021: Remainder of 2021 $ 112,118 2022 343,437 2023 341,200 2024 341,200 2025 341,200 Thereafter 1,603,424 Total lease payments 3,082,579 Less: imputed interest (60,398 ) Less: prepayments (2,475,459 ) Present value of lease liabilities $ 546,722 |
Short-Term Loans (Tables)
Short-Term Loans (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Short-term Loans | Short-term loans consisted of the following: Lender March 31, 2021 Maturity Date Int. Rate/Year Agricultural Bank of China-a^ 1,525,208 2022/2/27 5.66 % Agricultural Bank of China-b 305,041 2021/9/1 5.66 % Total short-term loans $ 1,830,249 Lender June 30, 2020 Maturity Date Int. Rate/Year Agricultural Bank of China-b* $ 282,896 2020-8-22 5.60 % Agricultural Bank of China-a 636,517 2020-12-23 4.65 % Agricultural Bank of China-a 1,414,481 2021-2-24 5.66 % Total short-term loans $ 2,333,894 The loans outstanding were guaranteed by the following properties, entities or individuals: a. Guaranteed by a commercial credit guaranty company unrelated to the Company and also by Jiping Chen, a stockholder of the Company. b. Collateralized by the building owned by Xiaoyan Chen and Jing Chen, who are both related parties of the Company. Xiaoyan Chen is one of the shareholders of Ankang Longevity Group. Jing Chen is the sister of Xiaoyan Chen but not a shareholder of Ankang Longevity Group. * The Company repaid the loan in full on maturity date. ^ Upon the original maturity date of February 27, 2021, the Company signed a loan extension agreement with Agricultural Bank of Chin to extend the loan repayment date to February 27, 2022 with the same interest rate of 5.66% per annum. |
Acquisition (Tables)
Acquisition (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Business Combinations [Abstract] | |
Schedule of Estimated Useful Lives | The fair value of distribution rights and its estimated useful lives are as follows: Preliminary Fair Value Weighted Average Useful Life (in Years) Distribution rights $ 1,125,603 (a) (a) The distribution rights with no expiration date has been determined to have an indefinite life. |
Related Party Transactions (Tab
Related Party Transactions (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Related Party Transactions [Abstract] | |
Schedule of Outstanding Amounts Due from Related Parties | As of March 31, 2021 and June 30, 2020, the outstanding amounts due from related parties consisted of the following: March 31, 2021 June 30, 2020 Yang Bin $ 45,756 $ 42,434 Beijing Huiyinansheng Asset Management Co., Ltd (a.) 22,878 21,217 Wang Qiwei 61,773 57,288 Total due from related parties $ 130,407 $ 120,939 a. This company is wholly owned by one of the Company’s senior management. |
Schedule of Due to Related Parties | March 31, 2021 June 30, 2020 Wu Yang $ 97,690 $ 90,598 Wang Sai 91,293 90,629 Chen Jiping - 3,024 Zhou Guocong 547,974 648,308 Li Baolin 228,781 353,619 Zhao Min 165,638 169,741 Total due to related parties $ 1,131,376 $ 1,355,919 |
Taxes (Tables)
Taxes (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of Income Tax Expense (Benefits) | i) The components of the income tax expenses (benefits) were as follows: For the nine months ended For the three months ended 2021 2020 2021 2020 Current income tax provision (benefit) $ - $ 476,862 $ (83,106 ) $ 142,960 Deferred income tax benefit - (202,293 ) - (32,783 ) Total $ - $ 274,569 $ (83,106 ) $ 110,177 |
Schedule of Financial Reporting Basis and Tax Basis of Assets and Liabilities | March 31, 2021 June 30, 2020 Deferred tax assets: Allowance for doubtful accounts $ 1,291,461 $ 428,879 Inventory reserve 326,903 252,022 Net operating loss carry-forwards 544,267 504,754 Total 2,162,631 1,185,655 Valuation allowance (2,162,631 ) (1,185,655 ) Total deferred tax assets - - Deferred tax liability: Distribution rights (281,401 ) (260,972 ) Total deferred tax liability (281,401 ) (260,972 ) Deferred tax liability, net $ (281,401 ) $ (260,972 |
Schedule of Movement of Valuation Allowance | Movement of the valuation allowance: March 31, 2021 June 30, 2020 Beginning balance $ 1,185,655 $ 519,671 Current year addition 884,162 680,901 Exchange difference 92,814 (14,917 ) Ending balance $ 2,162,631 $ 1,185,655 |
Schedule of Taxes Payable | Taxes payable consisted of the following: March 31, 2021 June 30, 2020 Income tax payable $ 3,326,884 $ 3,424,043 Value added tax payable 561,854 522,615 Business tax and other taxes payable 6,466 6,026 Total tax payable 3,895,204 3,952,684 Less: current portion 3,329,182 3,386,662 Income tax payable - noncurrent portion $ 566,022 $ 566,022 |
Segment Reporting (Tables)
Segment Reporting (Tables) | 9 Months Ended |
Mar. 31, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Information by Segment | The following table presents summarized information by segment for the nine months ended March 31, 2021: For the nine months ended March 31, 2021 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 96,477 $ 6,761,663 $ 2,338,961 $ 9,197,101 Cost of revenue and related business and sales tax 287,629 5,792,488 5,870,789 11,950,906 Gross profit (loss) (191,152 ) 969,175 (3,531,828 ) (2,753,805 ) Gross profit (loss) % (198.1 )% 14.3 % (151.0 )% (29.9 )% The following table presents summarized information by segment for the nine months ended March 31, 2020: For the nine months ended March 31, 2020 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 144,659 $ 9,661,025 $ 8,844,031 $ 18,649,715 Cost of revenue and related business and sales tax 349,840 7,353,047 6,531,822 14,234,709 Gross profit (loss) (205,181 ) 2,307,978 2,312,209 4,415,006 Gross profit (loss) % (141.8 )% 23.9 % 26.1 % 23.7 % The following table presents summarized information by segment for the three months ended March 31, 2021: For the three months ended March 31, 2021 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 23,468 $ 1,352,938 $ 614,331 $ 1,990,737 Cost of revenue and related business and sales tax 157,001 1,342,583 1,498,469 2,998,053 Gross profit (loss) (133,533 ) 10,355 (884,138 ) (1,007,316 ) Gross profit (loss) % (569.0 )% 0.8 % (143.9 )% (50.6 )% The following table presents summarized information by segment for the three months ended March 31, 2020: For the three months ended March 31, 2020 Luobuma Herbal Other agricultural products products products Total Segment revenue $ 5,900 $ 2,821,425 $ 906,997 $ 3,734,322 Cost of revenue and related business and sales tax 80,683 2,125,927 1,117,588 3,324,198 Gross profit (loss) (74,783 ) 695,498 (210,591 ) 410,124 Gross profit (loss) % (1,267.5 )% 24.7 % (23.2 )% 11.0 % Total assets as of March 31, 2021 and June 30, 2020 were as follows: March 31, 2021 June 30, 2020 Luobuma products $ 5,348,926 $ 2,836,450 Herbal products 39,467,761 43,855,815 Other agricultural products 22,774,290 32,396,346 Total assets $ 67,590,977 $ 79,088,611 |
Organization and Nature of Op_2
Organization and Nature of Operations (Details Narrative) | May 02, 2017USD ($) | Mar. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Jun. 30, 2020USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Aug. 22, 2019USD ($) | Aug. 22, 2019CNY (¥) | Jun. 30, 2019USD ($) | Mar. 13, 2019USD ($) | Mar. 13, 2019CNY (¥) | Dec. 31, 2017USD ($) | Dec. 31, 2017CNY (¥) | Oct. 26, 2017 | May 02, 2017CNY (¥) | Dec. 10, 2016USD ($) | Dec. 10, 2016CNY (¥) | Jul. 14, 2006 | Dec. 30, 2004 |
Registered capital | $ 51,844,426 | $ 58,695,475 | $ 66,512,401 | $ 67,419,383 | $ 72,421,245 | $ 72,632,114 | |||||||||||||
Strategic Cooperation Agreement [Member] | Biorefinery [Member] | |||||||||||||||||||
Registered capital | $ 737,745 | ||||||||||||||||||
Description of business combination | On May 2, 2017, the Company entered into a Strategic Cooperation Agreement with Beijing Zhongke Biorefinery Engineering Technology Co., Ltd. ("Biorefinery"), a leading high-tech biomass refining company financially backed by the Chinese Academy of Sciences Institute of Process Engineering, to establish the Institute of Chinese Apocynum Industrial Technology Research ("ICAITR"). Pursuant to the Strategic Cooperation Agreement, the two parties agreed to establish the ICAITR, with the Company and Biorefinery owning 80% and 20% of the equity interests of ICAITR, respectively. | ||||||||||||||||||
RMB [Member] | Strategic Cooperation Agreement [Member] | Biorefinery [Member] | |||||||||||||||||||
Registered capital | ¥ | ¥ 5,000,000 | ||||||||||||||||||
Xinjiang Taihe [Member] | |||||||||||||||||||
Registered capital | $ 1,502,650 | ||||||||||||||||||
Xinjiang Taihe [Member] | RMB [Member] | |||||||||||||||||||
Registered capital | ¥ | ¥ 10,000,000 | ||||||||||||||||||
Runze [Member] | |||||||||||||||||||
Registered capital | $ 1,502,650 | ||||||||||||||||||
Runze [Member] | RMB [Member] | |||||||||||||||||||
Registered capital | ¥ | ¥ 10,000,000 | ||||||||||||||||||
Tianjin Tajite [Member] | |||||||||||||||||||
Ownership percentage | 51.00% | 51.00% | 51.00% | ||||||||||||||||
Registered capital | $ 2,100,000 | ||||||||||||||||||
Tianjin Tajite [Member] | RMB [Member] | |||||||||||||||||||
Registered capital | ¥ | ¥ 14,000,000 | ||||||||||||||||||
Tenjove Newhemp Biotechnology Co., Ltd [Member] | |||||||||||||||||||
Registered capital | $ 1,502,650 | ||||||||||||||||||
Tenjove Newhemp Biotechnology Co., Ltd [Member] | RMB [Member] | |||||||||||||||||||
Registered capital | ¥ | ¥ 10,000,000 | ||||||||||||||||||
Zhong Hemp [Member] | |||||||||||||||||||
Ownership percentage | 60.00% | 60.00% | |||||||||||||||||
Registered capital | $ 28,237,022 | ||||||||||||||||||
Zhong Hemp [Member] | RMB [Member] | |||||||||||||||||||
Registered capital | ¥ | ¥ 200,000,000 | ||||||||||||||||||
Tenet-Jove Technological Development Co., Ltd [Member] | |||||||||||||||||||
Ownership percentage | 100.00% | ||||||||||||||||||
Tenet-Jove Technological Development Co., Ltd [Member] | Tianjin Tenet Huatai Technological Development Co Ltd [Member] | |||||||||||||||||||
Ownership percentage | 90.00% |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details Narrative) | Dec. 22, 2017 | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Jun. 30, 2018USD ($) | Jun. 30, 2020USD ($) | Jul. 02, 2019USD ($) |
Allowance for doubtful accounts | $ 13,539,904 | $ 13,539,904 | $ 5,235,436 | |||||
Inventory reserve | 1,429,804 | 1,429,804 | 1,121,408 | |||||
Allowance for uncollectible advances to suppliers | 5,629,606 | 5,629,606 | 3,342,590 | |||||
Operating liabilities | 449,162 | 449,162 | 401,891 | $ 500,000 | ||||
Right of use assets | 3,022,178 | 3,022,178 | $ 3,227,895 | $ 360,000 | ||||
Impairment loss | ||||||||
U.S. corporate tax rate | 35.00% | 21.00% | ||||||
Statutory federal tax rate, percentage | 25.00% | 28.00% | ||||||
Income tax expenses | $ (83,106) | $ 110,177 | $ 274,569 | $ 744,766 | ||||
Transition tax payment, description | The Company elects to pay the transition tax over an eight-year period using specified percentages (eight percent per year for the first five years, 15 percent in year six, 20 percent in year seven, and 25 percent in year eight). | |||||||
Value added tax rate description | Before May 1, 2018, all of the Company's products that were sold in the PRC were subject to a Chinese value-added tax at a rate of 17% of the gross sales price. After May 1, 2018, the Company was subject a tax rate of 16%, and after April 1, 2019, the tax rate was further reduced to 13% based on the new Chinese tax law. | |||||||
Minimum [Member] | ||||||||
Percentage of voting stock | 20.00% | 20.00% | ||||||
Maximum [Member] | ||||||||
Percentage of voting stock | 50.00% | 50.00% | ||||||
Average Translation Rates [Member] | ||||||||
Foreign currency translation | 0.1542 | 0.1432 | 0.1542 | 0.1432 | ||||
Subsequent Fiscal Year [Member] | ||||||||
Statutory federal tax rate, percentage | 21.00% | |||||||
1 RMB [Member] | ||||||||
Foreign currency translation | 0.1525 | 0.1525 | 0.1414 | |||||
1 RMB [Member] | Average Translation Rates [Member] | ||||||||
Foreign currency translation | 0.1498 | 0.1426 | 0.1498 | 0.1426 | ||||
Land Use Rights [Member] | ||||||||
Estimated useful life | 50 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Schedule of Consolidated Assets and Liabilities and Income Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | |
Current assets | $ 56,020,245 | $ 56,020,245 | $ 59,519,998 | ||
Plant and equipment, net | 6,058,925 | 6,058,925 | 9,489,484 | ||
TOTAL ASSETS | 67,590,977 | 67,590,977 | 79,088,611 | ||
Total liabilities | (15,746,551) | (15,746,551) | (12,576,210) | ||
Net sales | 1,990,737 | $ 3,734,322 | 9,197,101 | $ 18,649,715 | |
Gross profit (loss) | (1,007,316) | 410,124 | (2,753,805) | 4,415,006 | |
Loss from operations | (6,056,780) | (3,631,880) | (16,465,735) | (5,269,110) | |
Net loss | (7,507,265) | (3,817,693) | (21,583,688) | (5,497,847) | |
VIEs and their Subsidiaries [Member] | |||||
Current assets | 52,240,926 | 52,240,926 | 58,350,565 | ||
Plant and equipment, net | 4,679,535 | 4,679,535 | 8,168,594 | ||
Other non-current assets | 4,369,823 | 4,369,823 | 11,054,954 | ||
TOTAL ASSETS | 61,290,284 | 61,290,284 | 77,574,113 | ||
Total liabilities | (7,046,069) | (7,046,069) | (6,189,172) | ||
Net assets | 54,244,215 | 54,244,215 | $ 71,384,941 | ||
Net sales | 1,971,082 | 3,731,867 | 9,115,071 | 18,565,197 | |
Gross profit (loss) | (873,783) | 484,907 | (2,562,654) | 4,620,187 | |
Loss from operations | (5,119,542) | (2,805,273) | (14,234,577) | (1,054,684) | |
Net loss | $ (6,591,598) | $ (3,030,057) | $ (19,443,845) | $ (1,323,411) |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details) | 9 Months Ended |
Mar. 31, 2021 | |
Buildings [Member] | Minimum [Member] | |
Property and equipment estimated useful lives | 20 years |
Buildings [Member] | Maximum [Member] | |
Property and equipment estimated useful lives | 50 years |
Machinery and Equipment [Member] | Minimum [Member] | |
Property and equipment estimated useful lives | 5 years |
Machinery and Equipment [Member] | Maximum [Member] | |
Property and equipment estimated useful lives | 10 years |
Motor Vehicles [Member] | Minimum [Member] | |
Property and equipment estimated useful lives | 5 years |
Motor Vehicles [Member] | Maximum [Member] | |
Property and equipment estimated useful lives | 10 years |
Office Equipment [Member] | Minimum [Member] | |
Property and equipment estimated useful lives | 5 years |
Office Equipment [Member] | Maximum [Member] | |
Property and equipment estimated useful lives | 10 years |
Farmland Leasehold Improvements [Member] | Minimum [Member] | |
Property and equipment estimated useful lives | 12 years |
Farmland Leasehold Improvements [Member] | Maximum [Member] | |
Property and equipment estimated useful lives | 18 years |
Inventories, Net - Schedule of
Inventories, Net - Schedule of Inventories, Net (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 298,414 | $ 958,206 |
Work-in-process | 1,757,429 | 529,655 |
Finished goods | 1,737,011 | 1,433,423 |
Less: inventory reserve | (1,429,804) | (1,121,408) |
Total inventories, net | $ 2,363,050 | $ 1,799,876 |
Property and Equipment, Net (De
Property and Equipment, Net (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation and amortization expense | $ 135,511 | $ 104,281 | $ 446,236 | $ 524,239 |
Property and Equipment, Net - S
Property and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Property and equipment, gross | $ 12,603,837 | $ 15,649,380 |
Less: accumulated depreciation and amortization | (6,544,912) | (6,159,896) |
Total property and equipment, net | 6,058,925 | 9,489,484 |
Buildings [Member] | ||
Property and equipment, gross | 8,157,093 | 11,525,458 |
Machinery and Equipment [Member] | ||
Property and equipment, gross | 927,978 | 860,610 |
Motor Vehicles [Member] | ||
Property and equipment, gross | 62,141 | 57,630 |
Office Equipment [Member] | ||
Property and equipment, gross | 249,272 | 231,174 |
Farmland Leasehold Improvements [Member] | ||
Property and equipment, gross | $ 3,207,353 | $ 2,974,508 |
Property and Equipment, Net -_2
Property and Equipment, Net - Schedule of Leasehold Improvements (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Total farmland leasehold improvements | $ 3,207,353 | $ 2,974,508 |
Blueberry Farmland Leasehold Improvements [Member] | ||
Total farmland leasehold improvements | 2,464,031 | 2,285,149 |
Yew Tree Planting Base Reconstruction [Member] | ||
Total farmland leasehold improvements | 276,063 | 256,021 |
Greenhouse Renovation [Member] | ||
Total farmland leasehold improvements | $ 467,259 | $ 433,338 |
Land Use Rights, Net (Details N
Land Use Rights, Net (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
Amortization expense | $ 9,840 | $ 9,293 | $ 28,822 | $ 27,720 |
Land Use Rights [Member] | ||||
Estimated useful life | 50 years | |||
Amortization period | 50 years |
Land Use Rights, Net - Schedule
Land Use Rights, Net - Schedule of Land Use Rights (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Land use rights | $ 1,696,485 | $ 1,573,325 |
Less: accumulated amortization | (432,802) | (377,382) |
Total land use rights, net | $ 1,263,683 | $ 1,195,943 |
Land Use Rights, Net - Schedu_2
Land Use Rights, Net - Schedule of Estimated Future Amortization Expenses (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2022 | $ 33,930 | |
2023 | 33,930 | |
2024 | 33,930 | |
2025 | 33,930 | |
2026 | 33,930 | |
Thereafter | 1,094,033 | |
Total land use rights, net | $ 1,263,683 | $ 1,195,943 |
Distribution Rights (Details Na
Distribution Rights (Details Narrative) - Mar. 31, 2021 | USD ($) | CNY (¥) |
Distribution rights | $ | $ 1,125,603 | |
RMB [Member] | ||
Distribution rights | ¥ | ¥ 7,380,000 |
Investments (Details Narrative)
Investments (Details Narrative) | Oct. 21, 2013USD ($) | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Mar. 31, 2021CNY (¥) | Mar. 05, 2021USD ($) | Oct. 21, 2013CNY (¥) |
Income (loss) of equity method investments | $ (3,753,280) | $ 97,528 | ||||||
Shaanxi Pharmaceutical Group [Member] | ||||||||
Profit sharing on income, percentage | 29.00% | |||||||
Deductible statutory reserve, percentage | 30.00% | |||||||
Employee welfare fund, percentage | 10.00% | |||||||
Statutory reserve, percentage | 30.00% | |||||||
Zhejiang Zhen Ai Network Warehousing Services Co., Ltd [Member] | ||||||||
Investor payments | $ 2,200,000 | |||||||
RMB [Member] | Zhejiang Zhen Ai Network Warehousing Services Co., Ltd [Member] | ||||||||
Investor payments | ¥ | ¥ 14,500,000 | |||||||
Ankang Retail Chain Co., Ltd [Member] | Two Equity Investment Agreements [Member] | ||||||||
Investor payments | $ 1,000,000 | |||||||
Income (loss) of equity method investments | $ 1,777,551 | $ 43,054 | 3,753,280 | 97,528 | ||||
Ankang Retail Chain Co., Ltd [Member] | Two Equity Investment Agreements [Member] | Sunsimiao Drugstores [Member] | ||||||||
Percentage of ownership interest | 49.00% | |||||||
Ankang Retail Chain Co., Ltd [Member] | Two Equity Investment Agreements [Member] | Shaanxi Pharmaceutical Holding Group Longevity Pharmacy Co., Ltd. [Member] | ||||||||
Percentage of ownership interest | 49.00% | |||||||
Ankang Retail Chain Co., Ltd [Member] | Two Equity Investment Transfer Agreements [Member] | ||||||||
Income (loss) of equity method investments | 1,748,459 | 1,748,459 | ||||||
Ankang Retail Chain Co., Ltd [Member] | Supplemental Agreement [Member] | ||||||||
Income (loss) of equity method investments | ||||||||
Ankang Retail Chain Co., Ltd [Member] | RMB [Member] | Two Equity Investment Agreements [Member] | ||||||||
Investor payments | $ 6,860,000 | |||||||
Ankang Retail Chain Co., Ltd [Member] | 2013 [Member] | ||||||||
Investor payments | $ 1,000,000 | $ 1,000,000 | ||||||
Ankang Retail Chain Co., Ltd [Member] | 2013 [Member] | Shaanxi Pharmaceutical Group [Member] | ||||||||
Percentage of ownership interest | 7.00% | 7.00% | 7.00% | |||||
Ankang Retail Chain Co., Ltd [Member] | 2013 [Member] | Supplemental Agreement [Member] | ||||||||
Percentage of ownership interest | 49.00% | 49.00% | 49.00% | |||||
Ankang Retail Chain Co., Ltd [Member] | 2013 [Member] | RMB [Member] | ||||||||
Investor payments | ¥ | ¥ 6,800,000 | |||||||
Sunsimiao Drugstores [Member] | 2013 [Member] | ||||||||
Percentage of ownership interest | 49.00% | 49.00% | 49.00% |
Investments - Schedule of Inves
Investments - Schedule of Investments in Unconsolidated Entities (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Total investment | $ 4,515,124 | |
Shaanxi Pharmaceutical Holding Group Longevity Pharmacy Co., Ltd. [Member] | ||
Total investment | 3,690,419 | |
Shaanxi Pharmaceutical Sunsimiao Drugstores Ankang Chain Co., Ltd. [Member] | ||
Total investment | $ 824,705 |
Investments - Schedule of Finan
Investments - Schedule of Financial Information of Unconsolidated Entities (Details) - USD ($) | 9 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | |
Investments, All Other Investments [Abstract] | |||
Current assets | $ 38,546,879 | ||
Noncurrent assets | 324,725 | ||
Current liabilities | $ 29,671,104 | ||
Net sales | 21,199,520 | $ 23,490,467 | |
Gross profit | 1,748,858 | 2,236,670 | |
Income from operations | (4,065,801) | 195,147 | |
Net income | $ (4,091,472) | $ 199,037 |
Leases (Details Narrative)
Leases (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | Jul. 02, 2019 | |
Operating lease ROU assets | $ 3,022,178 | $ 3,022,178 | $ 3,227,895 | $ 360,000 | ||
Operating lease liabilities | 546,722 | $ 546,722 | ||||
Lease term, description | The Company considers those renewal or termination options that are reasonably certain to be exercised in the determination of the lease term and initial measurement of right of use assets and lease liabilities. Lease expense for lease payment is recognized on a straight-line basis over the lease term. Leases with initial term of 12 months or less are not recorded on the balance sheet. | |||||
Rent expenses | $ 112,171 | $ 106,175 | $ 337,128 | $ 307,503 | ||
Minimum [Member] | ||||||
Operating lease term | 5 years | 5 years | ||||
Maximum [Member] | ||||||
Operating lease term | 24 years | 24 years | ||||
Offices Space [Member] | Minimum [Member] | ||||||
Operating lease term | 1 year | 1 year | ||||
Offices Space [Member] | Maximum [Member] | ||||||
Operating lease term | 6 years | 6 years | ||||
Operatin Lease Liabilities [Member] | ||||||
Operating lease ROU assets | $ 3,022,178 | $ 3,022,178 | 3,227,895 | 3,587,788 | ||
Operating lease liabilities | $ 546,722 | $ 546,722 | $ 499,524 | $ 450,123 |
Leases - Schedule of Operating
Leases - Schedule of Operating Lease Related Assets and Liabilities (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 | Jul. 02, 2019 |
ROU lease assets | $ 3,022,178 | $ 3,227,895 | $ 360,000 |
Operating lease liabilities - current | 97,560 | 97,633 | |
Operating lease liabilities - non-current | 449,162 | 401,891 | 500,000 |
Total operating lease liabilities | 546,722 | ||
Operatin Lease Liabilities [Member] | |||
ROU lease assets | 3,022,178 | 3,227,895 | 3,587,788 |
Operating lease liabilities - current | 97,560 | 97,633 | |
Operating lease liabilities - non-current | 449,162 | 401,891 | |
Total operating lease liabilities | $ 546,722 | $ 499,524 | $ 450,123 |
Leases - Schedule of Weighted A
Leases - Schedule of Weighted Average Remaining Lease Terms and Discount Rates for Operating Leases (Details) | Mar. 31, 2021 | Jun. 30, 2020 |
Leases [Abstract] | ||
Weighted average remaining lease term (years) | 9 years 2 months 16 days | 9 years 3 months 4 days |
Weighted average discount rate | 5.00% | 5.00% |
Leases - Schedule of Maturities
Leases - Schedule of Maturities of Lease Liabilities (Details) | Mar. 31, 2021USD ($) |
Leases [Abstract] | |
Remainder of 2021 | $ 112,118 |
2022 | 343,437 |
2023 | 341,200 |
2024 | 341,200 |
2025 | 341,200 |
Thereafter | 1,603,424 |
Total lease payments | 3,082,579 |
Less: imputed interest | (60,398) |
Less: prepayments | (2,475,459) |
Present value of lease liabilities | $ 546,722 |
Short-Term Loans (Details Narra
Short-Term Loans (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | [3],[4] | |||
Interest expense | $ 25,627 | $ 26,166 | $ 88,894 | $ 84,432 | ||||
Weighted average interest rate | 5.50% | 4.53% | 5.36% | 5.03% | ||||
Agricultural Bank of China One [Member] | ||||||||
Maturity date | Feb. 27, 2022 | [1],[2] | Aug. 22, 2020 | |||||
Interes rate | 5.66% | [1],[2] | 5.66% | [1],[2] | 5.60% | |||
Agricultural Bank of China One [Member] | Loan Extension Agreement [Member] | ||||||||
Loan maturity description | Upon the original maturity date of February 27, 2021, the Company signed a loan extension agreement with Agricultural Bank of Chin to extend the loan repayment date to February 27, 2022 with the same interest rate of 5.66% per annum. | |||||||
Maturity date | Feb. 27, 2021 | |||||||
Interes rate | 5.66% | 5.66% | ||||||
[1] | Guaranteed by a commercial credit guaranty company, unrelated to the Company and also by Jiping Chen, a shareholder of the Company. | |||||||
[2] | Upon the original maturity date of February 27, 2021, the Company signed a loan extension agreement with Agricultural Bank of Chin to extend the loan repayment date to February 27, 2022 with the same interest rate of 5.66% per annum. | |||||||
[3] | Collateralized by the building owned by Xiaoyan Chen and Jing Chen, who are both related parties of the Company. Xiaoyan Chen is one of the shareholders of Ankang Longevity Group. Jing Chen is the sister of the Xiaoyan Chen but not a shareholder of Ankang Longevity Group. | |||||||
[4] | The Company repaid the loan in full on maturity date. |
Short-Term Loans - Schedule of
Short-Term Loans - Schedule of Short-term Loans (Details) - USD ($) | 9 Months Ended | 12 Months Ended | |||
Mar. 31, 2021 | Jun. 30, 2020 | ||||
Total short-term loans | $ 1,830,249 | $ 2,333,894 | |||
Agricultural Bank of China One [Member] | |||||
Total short-term loans | $ 1,525,208 | [1],[2] | $ 282,896 | [3],[4] | |
Maturity Date | Feb. 27, 2022 | [1],[2] | Aug. 22, 2020 | [3],[4] | |
Int. Rate/Year | 5.66% | [1],[2] | 5.60% | [3],[4] | |
Agricultural Bank of China Two [Member] | |||||
Total short-term loans | $ 305,041 | [3] | $ 636,517 | [1] | |
Maturity Date | Sep. 1, 2021 | [3] | Dec. 23, 2020 | [1] | |
Int. Rate/Year | 5.66% | [3] | 4.65% | [1] | |
Agricultural Bank of China Three [Member] | |||||
Total short-term loans | [1] | $ 1,414,481 | |||
Maturity Date | [1] | Feb. 24, 2021 | |||
Int. Rate/Year | [1] | 5.66% | |||
[1] | Guaranteed by a commercial credit guaranty company, unrelated to the Company and also by Jiping Chen, a shareholder of the Company. | ||||
[2] | Upon the original maturity date of February 27, 2021, the Company signed a loan extension agreement with Agricultural Bank of Chin to extend the loan repayment date to February 27, 2022 with the same interest rate of 5.66% per annum. | ||||
[3] | Collateralized by the building owned by Xiaoyan Chen and Jing Chen, who are both related parties of the Company. Xiaoyan Chen is one of the shareholders of Ankang Longevity Group. Jing Chen is the sister of the Xiaoyan Chen but not a shareholder of Ankang Longevity Group. | ||||
[4] | The Company repaid the loan in full on maturity date. |
Acquisition (Details Narrative)
Acquisition (Details Narrative) - Tianjin Tajite [Member] | 1 Months Ended | ||||
Dec. 31, 2016USD ($) | Dec. 31, 2016CNY (¥) | Oct. 26, 2017USD ($) | Oct. 26, 2017CNY (¥) | Dec. 12, 2016 | |
Acquire equity interest percentage | 51.00% | ||||
Business acquisition consideration amount | $ | $ 2,100,000 | ||||
Goodwill | $ | $ 2,100,000 | ||||
RMB [Member] | |||||
Business acquisition consideration amount | ¥ | ¥ 14,000,000 | ||||
Goodwill | ¥ | ¥ 14,010,195 |
Acquisition - Schedule of Estim
Acquisition - Schedule of Estimated Useful Lives (Details) - USD ($) | Dec. 12, 2016 | Mar. 31, 2021 | |
Preliminary Fair Value | $ 1,125,603 | ||
Tianjin Tenet [Member] | Distribution Rights [Member] | |||
Preliminary Fair Value | $ 1,125,603 | ||
Weighted Average Useful Life (in Years) | [1] | 0 years | |
[1] | The distribution rights with no expiration date has been determined to have an indefinite life. |
Related Party Transactions (Det
Related Party Transactions (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | |
Due to related parties | $ 1,131,376 | $ 1,131,376 | $ 1,355,919 | ||
Shaanxi Pharmaceutical Group [Member] | |||||
Sales to related party | 311,249 | $ 582,726 | 1,606,448 | $ 2,128,575 | |
Accounts receivable due from related parties | $ 1,567,160 |
Related Party Transactions - Sc
Related Party Transactions - Schedule of Outstanding Amounts Due from Related Parties (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 | |
Total due from related parties | $ 130,407 | $ 120,939 | |
Yang Bin [Member] | |||
Total due from related parties | 45,756 | 42,434 | |
Beijing Huiyinansheng Asset Management Co., Ltd [Member] | |||
Total due from related parties | [1] | 22,878 | 21,217 |
Wang Qiwei [Member] | |||
Total due from related parties | $ 61,773 | $ 57,288 | |
[1] | This Company is wholly owned by one of the Company's senior management. |
Related Party Transactions - _2
Related Party Transactions - Schedule of Due to Related Parties (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Total due to related parties | $ 1,131,376 | $ 1,355,919 |
Wu Yang [Member] | ||
Total due to related parties | 97,690 | 90,598 |
Wang Sai [Member] | ||
Total due to related parties | 91,293 | 90,629 |
Chen Jiping [Member] | ||
Total due to related parties | 3,024 | |
Zhou Guocong [Member] | ||
Total due to related parties | 547,974 | 648,308 |
Li Baolin [Member] | ||
Total due to related parties | 228,781 | 353,619 |
Zhao Min [Member] | ||
Total due to related parties | $ 165,638 | $ 169,741 |
Taxes (Details Narrative)
Taxes (Details Narrative) - USD ($) | 9 Months Ended | 12 Months Ended |
Mar. 31, 2021 | Jun. 30, 2018 | |
Income Tax Disclosure [Abstract] | ||
Income tax statutory rate | 25.00% | 28.00% |
Estimated income tax expense | $ 744,766 | |
Income taxes percentage, description | The Company elects to pay the transition tax over an eight-year period using specified percentages (eight percent per year for the first five years, 15 percent in year six, 20 percent in year seven, and 25 percent in year eight). | |
Value added tax rate, description | The applicable VAT rate was 17% before May 1, 2018 for products sold in the PRC and decreased to 16% thereafter, and after April 1, 2019, the tax rate was further reduced to 13% based on the new Chinese tax law. The amount of VAT liability is determined by applying the applicable tax rate to the invoiced amount of goods sold (output VAT) less VAT paid on purchases made with the relevant supporting invoices (input VAT). Under commercial practice in the PRC, the Company pays VAT based on tax invoices issued. |
Taxes - Schedule of Components
Taxes - Schedule of Components of Income Tax Expense (Benefits) (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2018 | |
Income Tax Disclosure [Abstract] | |||||
Current income tax provision | $ (83,106) | $ 142,960 | $ 476,862 | ||
Deferred income tax provision (benefit) | (32,783) | (202,293) | |||
Total income tax expense | $ (83,106) | $ 110,177 | $ 274,569 | $ 744,766 |
Taxes - Schedule of Financial R
Taxes - Schedule of Financial Reporting Basis and Tax Basis of Assets and Liabilities (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 | Jun. 30, 2019 |
Income Tax Disclosure [Abstract] | |||
Allowance for doubtful accounts | $ 1,291,461 | $ 428,879 | |
Inventory reserve | 326,903 | 252,022 | |
Net operating loss carry-forwards | 544,267 | 504,754 | |
Total | 2,162,631 | 1,185,655 | |
Valuation allowance | (2,162,631) | (1,185,655) | $ (519,671) |
Total deferred tax assets | |||
Distribution rights | (281,401) | (260,972) | |
Total deferred tax liability | (281,401) | (260,972) | |
Deferred tax assets (liability), net | $ (281,401) | $ (260,972) |
Taxes - Schedule of Movement of
Taxes - Schedule of Movement of Valuation Allowance (Details) - USD ($) | 9 Months Ended | 12 Months Ended |
Mar. 31, 2021 | Jun. 30, 2020 | |
Income Tax Disclosure [Abstract] | ||
Beginning balance | $ 1,185,655 | $ 519,671 |
Current year addition | 884,162 | 680,901 |
Exchange difference | 92,814 | (14,917) |
Ending balance | $ 2,162,631 | $ 1,185,655 |
Taxes - Schedule of Taxes Payab
Taxes - Schedule of Taxes Payable (Details) - USD ($) | Mar. 31, 2021 | Jun. 30, 2020 |
Income Tax Disclosure [Abstract] | ||
Income tax payable | $ 3,326,884 | $ 3,424,043 |
Value added tax payable | 561,854 | 522,615 |
Business tax and other taxes payable | 6,466 | 6,026 |
Total tax payable | 3,895,204 | 3,952,684 |
Less: current portion | 3,329,182 | 3,386,662 |
Income tax payable - noncurrent portion | $ 566,022 | $ 566,022 |
Stockholders' Equity (Details N
Stockholders' Equity (Details Narrative) - USD ($) | Jan. 27, 2021 | Dec. 10, 2020 | Jul. 10, 2020 | Sep. 05, 2019 | Sep. 03, 2019 | Sep. 28, 2016 | Mar. 31, 2021 | Mar. 31, 2021 | Mar. 31, 2020 | Aug. 14, 2020 | Jun. 30, 2020 |
Shares issued | 604,900 | 310,977 | |||||||||
Common stock at a price | $ 2.73 | $ 4.68 | $ 5.54 | ||||||||
Gross proceeds from initial public offering, value | $ 1,643,087 | $ 1,500,203 | $ 1,093,335 | $ 2,736,422 | $ 2,522,863 | ||||||
Statutory surplus reserve percentage | 10.00% | ||||||||||
Registered capital reserve | 50.00% | ||||||||||
Statutory reserves | $ 4,198,107 | $ 4,198,107 | $ 4,198,107 | ||||||||
Number of restricted shares granted | 184,763 | ||||||||||
Number of restricted shares granted, value | $ 1,022,660 | ||||||||||
Reverse stock split description | 1-for-9 reverse stock split | ||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | |||||||
Reverse stock split, par value | $ 0.001 | ||||||||||
Common stock, shares outstanding | 4,009,288 | 4,009,288 | 27,333,428 | 3,039,943 | |||||||
Proceeds from issuance of common stock | $ 2,736,422 | $ 1,500,203 | |||||||||
Two Investors [Member] | |||||||||||
Shares issued | 364,445 | ||||||||||
Common stock at a price | $ 3 | ||||||||||
Proceeds from issuance of common stock | $ 1,093,355 | ||||||||||
After Reverse Stock Split [Member] | |||||||||||
Common stock, shares outstanding | 3,037,048 | ||||||||||
IPO [Member] | |||||||||||
Shares issued | 190,354 | ||||||||||
Common stock at a price | $ 40.50 | ||||||||||
Gross proceeds from initial public offering, value | $ 7,700,000 | ||||||||||
Net proceeds from initial public offering, net of offering costs | $ 5,400,000 |
Concentrations and Risks (Detai
Concentrations and Risks (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | |
Sales Revenue, Net [Member] | Customer One [Member] | |||||
Concentration risk, percentage | 16.00% | 19.00% | 17.00% | 14.00% | |
Sales Revenue, Net [Member] | Customer Two [Member] | |||||
Concentration risk, percentage | 13.00% | 16.00% | 15.00% | 11.00% | |
Sales Revenue, Net [Member] | Customer Three [Member] | |||||
Concentration risk, percentage | 12.00% | 14.00% | 14.00% | ||
Sales Revenue, Net [Member] | Customer Four [Member] | |||||
Concentration risk, percentage | 10.00% | 10.00% | |||
Accounts Receivable [Member] | Vendor Five [Member] | |||||
Concentration risk, percentage | 72.00% | ||||
Purchases [Member] | Vendor Five [Member] | |||||
Concentration risk, percentage | 13.00% | ||||
Purchases [Member] | Vendor One [Member] | |||||
Concentration risk, percentage | 48.00% | 22.00% | 53.00% | 34.00% | |
Purchases [Member] | Vendor Two [Member] | |||||
Concentration risk, percentage | 10.00% | 21.00% | 11.00% | 16.00% | |
Purchases [Member] | Vendor Three [Member] | |||||
Concentration risk, percentage | 17.00% | 11.00% | |||
Purchases [Member] | Vendor Four [Member] | |||||
Concentration risk, percentage | 15.00% | 10.00% | |||
Purchases [Member] | Vendor Six [Member] | |||||
Concentration risk, percentage | 12.00% | ||||
China [Member] | |||||
Cash balance | $ 25,831,506 | $ 25,831,506 | $ 32,358,252 | ||
Concentration risk, percentage | 100.00% | 100.00% |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) - USD ($) | May 16, 2017 | Mar. 31, 2021 |
Damages amount | $ 6,000,000 | |
Settlement Agreement and Release [Member] | ||
Payment to plantiff | $ 47,500 |
Segment Reporting (Details Narr
Segment Reporting (Details Narrative) | 9 Months Ended |
Mar. 31, 2021Integer | |
Segment Reporting [Abstract] | |
Operating segments | 3 |
Segment Reporting - Schedule of
Segment Reporting - Schedule of Information by Segment (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Jun. 30, 2020 | |
Segment revenue | $ 1,990,737 | $ 3,734,322 | $ 9,197,101 | $ 18,649,715 | |
Cost of revenue and related business and sales tax | 2,998,053 | 3,324,198 | 11,950,906 | 14,234,709 | |
Gross profit (loss) | $ (1,007,316) | $ 410,124 | $ (2,753,805) | $ 4,415,006 | |
Gross profit (loss) % | (50.60%) | 11.00% | (29.90%) | 23.70% | |
Assets | $ 67,590,977 | $ 67,590,977 | $ 79,088,611 | ||
Luobuma Products [Member] | |||||
Segment revenue | 23,468 | $ 5,900 | 96,477 | $ 144,659 | |
Cost of revenue and related business and sales tax | 157,001 | 80,683 | 287,629 | 349,840 | |
Gross profit (loss) | $ (133,533) | $ (74,783) | $ (191,152) | $ (205,181) | |
Gross profit (loss) % | (569.00%) | (1267.50%) | (198.10%) | (141.80%) | |
Assets | $ 5,348,926 | $ 5,348,926 | 2,836,450 | ||
Herbal Products [Member] | |||||
Segment revenue | 1,352,938 | $ 2,821,425 | 6,761,663 | $ 9,661,025 | |
Cost of revenue and related business and sales tax | 1,342,583 | 2,125,927 | 5,792,488 | 7,353,047 | |
Gross profit (loss) | $ 10,355 | $ 695,498 | $ 969,175 | $ 2,307,978 | |
Gross profit (loss) % | 0.80% | 24.70% | 14.30% | 23.90% | |
Assets | $ 39,467,761 | $ 39,467,761 | 43,855,815 | ||
Other Agricultural Products [Member] | |||||
Segment revenue | 614,331 | $ 906,997 | 2,338,961 | $ 8,844,031 | |
Cost of revenue and related business and sales tax | 1,498,469 | 1,117,588 | 5,870,789 | 6,531,822 | |
Gross profit (loss) | $ (884,138) | $ (210,591) | $ (3,531,828) | $ 2,312,209 | |
Gross profit (loss) % | (143.90%) | (23.20%) | (151.00%) | 26.10% | |
Assets | $ 22,774,290 | $ 22,774,290 | $ 32,396,346 |